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i.e. Id est; that is 
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l Liter 
LB Luria-Bertani 
m Milli 
M Molar 
MFD Multiparameter fluorescence detection 
min Minute 
MW Molecular weight 
n Nano 
NaOAc Sodium acetate 
o/n Overnight 
OD Optical density 
p pico 
PAGE Polyacrylamide gel electrophoresis 
PCR Polymerase chain reaction 
rpm Rotations per minute 
SDS Sodium dodecyl sulfate 
sec Second 
TCEP Tris(2-carboxyethyl)phosphine 
TEMED Tetramethylethylenediamine 
UV Ultraviolet 
vs. versus 
v/v Volume/volume 
w/v Weight/volume 
μ Micro 
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1. Introduction 
 
1.1. Restriction-modification systems in bacteria 
 
The phenomenon of restriction was first observed in the early 1950s, when some bacterial 
strains were observed to show the property of inhibiting the reproduction of viruses 
previously grown on different strains [1, 2]. This effect was connected to sequence-specific 
endonucleases [2]. Restriction-modification (R-M) systems consist of pairs of opposing 
enzyme activities: restriction endonuclease and methyltransferase activity [3], and their main 
function is the defence of the host organism against foreign DNA [4]. The mechanism of 
defence consists of the recognition of the incoming foreign DNA and cleaving at defined 
recognition sites [5]. Foreign DNA lacks specific modification within the recognition site, 
while the host DNA is modified by its methyltransferase at these sites, and thus is resistant to 
cleavage [5] (Figure 1.1). Recognition sequences are usually 4 to 8 bp long, continuous or 
interrupted, symmetric or asymmetric, unique or degenerate [3]. Restriction endonucleases 
and methyltransferases from the same system recognize the same sequence. 
Methyltransferases add one methyl group to adenine or cytosine in each strand of the 
recognition sequence, which sterically blocks restriction enzyme:DNA binding, and prevents 
host genome cleavage by the restriction enzyme [3].  
Restriction endonucleases catalyze double strand breaks in DNA, within or close or at a 
random distance (depending on the type) to the recognition sequence, requiring (with few 
exceptions) the presence of Mg2+ [3, 6].  
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Figure 1.1 Schematic view of bacteriophage infection and host defence. RE – restriction 
enzyme (here EcoRV as an example), M – modification enzyme. Detailed explanation in the text. 
 
Restriction modification systems occur in archaea, bacteria [7, 8] and certain viruses [9]. Up 
to date, almost 4000 different R-M systems have been identified [10]. Also, many different R-
M systems can be present in one species: Neisseria gonorrhoeae has 16 biochemically 
identified R-M systems [11]. Helicobacter pylori and Methanococcus jannaschii have 30 and 
13 genes for methyltransferase identified, respectively, that could belong to R-M systems 
[12].  
Although most of restriction endonucleases and methyltransferases are coded together in the 
genome, there are some exceptions. Escherichia coli has two methyltransferases unlinked to 
the respective endonucleases, Dam (DNA-adenine methyltransferase) and Dcm (DNA-
cytosine methyltransferase) [13]. Dam is involved in Dam-directed mismatch repair [14], as 
well as in gene regulation [13], while Dcm is required for very short patch (VSP) mismatch 
repair [15, 16].  
Restriction endonucleases differ in structure, recognition site, cleavage site and required 
cofactors, and based on these differences they are classified into 4 types: Type I, Type II, 
Type III and Type IV [17].  
Type I restriction enzymes have three different subunits, HsdM (responsible for 
modification), HsdR (responsible for restriction) and HsdS (responsible for sequence 
recognition) [18]. The holoenzyme consists of two modification subunits, two restriction 
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subunits and one sequence recognition subunit. They require ATP, Mg2+ and AdoMet (S-
Adenosylmethionine) for activity, and recognize two asymmetric bi-partite recognition sites, 
cleaving approximately half way between the sites [19].  
Type III restriction enzymes have two different subunits, Mod (responsible for DNA 
recognition and modification) and Res (responsible for cleavage), in Mod2Res2 stoichiometry 
[18]. They require ATP and Mg2+ for activity, and recognize two copies of head-to-head 
oriented recognition sequences, cleaving close to one of them [20].  
Type IV restriction enzymes are not part of R-M systems, since they recognize and cleave 
only methylated DNA [17]. A typical representative of this group is McrBC, which consists 
of two subunits, McrB (responsible for DNA recognition) and McrC (responsible for 
cleavage) [21]. It requires GTP and Mg2+ for activity, and at least two RmC sequences (purine 
followed by methylated cysteine), cleaving close to one of the recognition sites [18, 22].  
Since BsoBI is a Type II restriction enzyme, this group of enzymes will be discussed in more 
details. 
 
1.2. Type II restriction enzymes 
 
Type II restriction enzymes are well studied, with many reviews available [5, 6, 23, 24]. Type 
II REases are very powerful tools for genetic engineering, and thus very well genetically and 
biochemically characterized (there are more than 3500 Type II REases in the REBASE 
database from 2007) [10]. The orthodox Type II REase recognizes 4 to 8 bp long sequences, 
and cleaves both DNA strands within or close to the recognition site, leaving 3’-OH and 5’-
phosphate ends (Figure 1.2). The catalytic mechanism shown in Figure 1.2 is also known as 
associative mechanism, in which the transition bypyramidal state is formed before the bond 
cleavage. However, the latest computational studies on the EcoRV restriction enzyme suggest 
that the most probable catalytic mechanism is dissociative, and that Mg2+ ions might have the 
role of activating the water molecule involved in nucleophilic attack [25]. Type II REases are 
usually homodimeric or homotetrameric, and do not require ATP or GTP, but usually (with 
some exceptions) only Mg2+ as cofactor. 
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Figure 1.2 Hydrolysis of a phosphodiester bond. General base (X) activates hydroxyl from 
water molecule which makes a nucleophilic attack at the phosphorus atom in the 
phosphodiester bond, leaving the phosphoryl group attached to the 5’ end. The negatively 
charged leaving group is protonated by a general acid (Z). The bond that is cleaved is shown in 
red. 
 
Many Type II REases do not have these orthodox characteristics, so the division into 
subgroups was necessary, based on cleaved sequence or the structure of the enzymes [17]. 
However, due to the great diversity among Type II REases, overlaps cannot be avoided. The 
subgroups of Type II enzymes are listed below, and for a more detailed description see 
references [5, 17, 26].  
Type IIA enzymes recognize an asymmetric sequence, and cleave within or a few base pairs 
away from the sequence. Typical representatives of this group are: FokI, Bpu10I and AciI. 
Type IIB enzymes cleave both strands of DNA at both sides of the recognition sequence. 
Typical representatives are BplI and BcgI.  
Type IIC enzymes are all Type II enzymes that have both cleavage and modification domains 
within one polypeptide. Due to this structural characteristic, many Type IIB, Type IIG and 
Type IIH enzymes are classified also as Type IIC enzymes (e.g. BcgI, HaeIV). They 
recognize both symmetric and asymmetric target sequences.  
Type IIE enzymes interact with two copies of the recognition sequence, where one copy is 
the target for cleavage, and the other, in cis or trans, is serving as the allosteric effector. 
Typical examples and well studied Type IIE enzymes are EcoRII and NaeI.  
Type IIF enzymes are usually homotetramers and interact with two copies of recognition 
sequence, cleaving both of them. Typical examples are SfiI and NgoMIV.  
Type IIG enzymes are very similar to Type IIC enzymes, having both cleavage and 
modification domains in a single polypeptide. The only difference is that they may be 
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stimulated by AdoMet, and thus they were previously classified as Type IV enzymes. Typical 
representatives are Eco57I and BsgI.  
Type IIH enzymes have the same genetic organization as Type I enzymes, but biochemically 
behave as Type II enzymes. They can recognize symmetric or asymmetric sequences, and 
typical representatives are AhdI and PshAI. 
Type IIM enzymes recognize specific methylated sequence and cleave at a fixed site. They 
should not be mixed up with Type IV REases, since those enzymes do not have a defined 
DNA cleavage site. The best studied representative is DpnI.  
Type IIP enzymes are homodimeric and recognize symmetric (palindromic) sequences and 
cleave at fixed symmetrical locations within or immediately adjacent to the sequence. 
Recognition sequences can be interrupted with segments of unspecified sequences, but 
specified length. The products can have “blunt” or “sticky” ends (with 3’- or 5’-overhangs). 
Most of the enzymes used for genetic engineering belong to this subgroup, and thus many of 
them are well studied, e.g. EcoRI and EcoRV.  
Type IIS subgroup of enzymes is the earliest identified group of Type II REases. They 
recognize asymmetric sequences, similar to Type IIA enzymes, but cleave at least one DNA 
strand outside of the recognition sequence (the cleavage site is shifted away from the 
recognition site). The best known representative of this group is FokI, whose structural 
information helped determining structural information of other enzymes from this group.  
Type IIT enzymes are heterodimers and can recognize both symmetric and asymmetric 
sequences. Typical examples are Bpu10I and BslI.  
Some Type II enzymes cleave only one DNA strand, and these enzymes are called nicking 
enzymes. Some of the examples include Nt.BstNBI, Nt.BstSEI and Nt.CviPII (where Nt 
stands for nicking the top strand). Some of the nicking enzymes play a role in mismatch 
repair, where they nick the G/T mismatch resulting from deamination of 5mC within the 
recognition sequence of the accompanied MTase.  
Although Type II REases are extensively studied, many of them have not been characterized 
in details, and for many of them it is not yet known to which group they belong. However, it 
can be concluded that the range of cleavage modes is much larger than previously expected, 
as has been shown in [27].  
Although restriction enzymes and methyltransferases from the same RM system recognize the 
same DNA sequence, they do not have strong amino acid sequence similarity, and their target 
recognition domains are usually different [7, 28, 29]. However, different methyltransferases 
have strong amino acid sequence similarity, with the target recognition domain being the 
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largest variable region [30-34]. Based on these properties, it is assumed that restriction 
endonucleases and methyltranferases from Type II system are the result of independent 
evolution. Methyltransferases probably evolved as enzymes with important function in gene 
regulation or replication, providing a genetic background of methylated genome in which 
restriction endonucleases could evolve [7].  
 
1.3. BsoBI restriction enzyme 
 
BsoBI is a thermostable Type IIP restriction enzyme, purified from the thermophilic gram-
positive bacterium Bacillus stearothermophilus [35]. It recognizes the 6 bp symmetric 
sequence 5’-CYCGRG-3’ (where Y represents pyrimidine, and R represents purine), and 
cleaves between the first and the second base [36, 37]. It requires Mg2+ ions for double strand 
cleavage and has the optimal cleavage temperature of 65 °C [36]. Crystallographic studies had 
shown that BsoBI is a homodimer which completely encircles the DNA, so that the 
recognition sequence lies within a 20 Å long tunnel formed by the protein, which excludes 
water molecules form the solvent (Figure 1.3) [38]. Each subunit of BsoBI contains 323 
amino acids and has a molecular weight of 36.7 kDa. The analysis of the crystal structure 
showed that protein-DNA interactions are symmetric and that there are no significant 
differences between the two active sites [38].  
 
                               
Figure 1.3 Structure of the BsoBI-DNA complex. a) The protein subunits (shown in blue and 
red) encircle the DNA (shown in grey) b) Molecular surface of the protein, showing complete 
enclosure of DNA in the tunnel 
 
BsoBI belongs to the EcoRI family of restriction enzymes. This family shares the common 
PD…D/ExK motif in the catalytic site, where x represents a hydrophobic residue [39]. Three 
charged residues are arranged near the reactive phosphate group of the phosphodiester bond to 
Catalytic domain 
Helical domain 
a b 
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be cleaved, and an additional catalytic residue (acidic) is present at different positions in 
different REases (Figure 1.4) [39]. The three catalytic residues in BsoBI are D212, E240 and 
K242. Structurally equivalent to the fourth residue in BsoBI is D201, but it cannot be 
involved in catalysis since it is well removed from the active site [38]. Thus, H253 was 
proposed as putative catalytic residue, positioned to act as a general base during catalysis 
[38]. Apart from this His253, residue Glu252 was proposed as an important catalytic residue, 
which may be involved in metal ion binding [38]. Although histidines can be effective general 
bases, they were not seen in restriction endonucleases so far, and BsoBI could be the first 
enzyme that has histidine-mediated catalysis. 
 
   
Figure 1.4 Catalytic sites of EcoRI (a) and BsoBI (b). DNA is shown in black, and bases 
between which the cleavage occurs are shown in red. The putative BsoBI catalytic residue 
His253 is shown in green. Detailed explanation in the text. 
 
Putative catalytic residues of BsoBI were also analyzed by random mutagenesis [36]. 
Mutations in residues D124, D212, D246 and E252 led to the loss of catalytic activity, but not 
binding activity, thus these residues were proposed to be located near or within the active site 
[36]. In the same study histidine residue 253 was found to be an important catalytic residue.  
The helical domain of BsoBI (see Figure 1.3) forms a compact structure with an important 
role in dimerization, but it also makes several contacts with DNA, especially with the 
uncleaved strand [38]. The catalytic domain is less compact and has a similar topology as the 
other enzymes from the EcoRI family. The gap between subunits is too small to allow DNA 
entry, so there must be large conformational changes prior to DNA binding. So far, only the 
structure of BsoBI with bound specific DNA was solved, and all attempts to crystallize the 
enzyme without DNA failed, which suggested a high mobility structure in the absence of 
DNA [38]. Based on the available crystal structure, it can be seen that the interface between 
the catalytic domains is much weaker than the one between the helical domains, so it could be 
a b 
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expected to see conformational changes in this part of the molecule. Determination of these 
conformational changes was one of the main questions of this work.  
 
1.4. Fluorescence spectroscopy of single molecules in solution 
 
Fluorescence spectroscopy methods were considered as primary methods in biophysics and 
biochemistry, but recently their use is expanding to other areas of research, e.g. biotechnology 
or cellular and molecular imaging. The reason is the fact that fluorescence is highly sensitive, 
it can cover a wide range of timescales (from femtoseconds to seconds, or longer), and it can 
be used to selectively examine certain molecules in complex mixtures, when it is combined 
with different single-molecule techniques [40-44].  
Single-molecule experiments allow for separating subpopulations of macromolecules in 
solution, which would otherwise be hidden in ensemble experiments. They can provide 
information about time trajectories and distributions of these subpopulations, identify and sort 
them based on their properties [43, 45].  
 
 
Figure 1.5 The difference between ensemble and single-molecule experiments. a) Ensemble 
experiment where a large volume of highly concentrated molecules is observed, b) “Small 
ensemble” experiment where a smaller volume of diluted molecules is observed, c) Single-
molecule experiment where a small volume of highly diluted molecules is observed, and single 
fluorescence bursts can be seen (adapted from Mukhopadhyay et al. [42]). 
a 
b 
c 
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Despite these advantages, certain criteria have to be fulfilled, and Figure 1.5 represents the 
transition between ensemble and single-molecule experiments, as well as the necessary 
conditions for a successful single-molecule setup.  
In ensemble experiments, the output signal represents the average of all different 
subpopulations of molecules present in the solution. Usually, the observation volume is large 
and the concentration of investigated species is high. Lowering the observation volume, as 
well as the solution concentration, enables observation of single fluorescence bursts derived 
from single fluorescent molecule. In the setup used in this study, the observation volume was 
in the range of femtoliters, and the protein concentration used was 40-80 pM, conditions that 
allowed only one molecule at a time to pass through the observation volume.  
The extent of energy transfer between donor and acceptor fluorophore in fluorescence 
resonance energy transfer (FRET) gives information about distances between those two 
fluorophores. Optimal distances that could be investigated using FRET are between 10 and 
100 Å, which are typical distances in biomolecules. This fact makes FRET a very useful 
technique for the investigation of protein and DNA dynamics, protein folding, replication, 
transcription, translation and many other fundamental biological processes [46]. Typical 
FRET setups use one donor fluorophore and one acceptor fluorophore (so-called single-pair 
FRET), which allows the examination of biomolecules in one dimension (Figure 1.6).  
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Figure 1.6 Schematic representation of intramolecular FRET. The FRET efficiency depends 
strongly on the distance between two fluorophores. The distance equal to the R0 value for 
certain donor/acceptor pair leads to 50 % of FRET efficiency; longer distance leads to lower 
FRET, while shorter distance leads to higher FRET efficiency. D – donor fluorophore; A – 
acceptor fluorophore. 
 
1.5. Structural dynamics of proteins probed by single-molecule techniques 
 
For more than 30 years it is known that enzymes are not static but flexible structures [47-49] 
and this flexibility was shown to be crucial for various enzymatic functions, such as catalysis, 
allosteric regulation or ligand binding induced conformational changes [50-52]. 
Conformational rearrangements have wide range of timescales (from femtosecond timescale 
for bond vibrations to second timescale for large conformational rearrangements [Figure 1.7]) 
and are considered intrinsic features of all proteins. Although X-ray crystallography has 
provided important insight into different conformations one enzyme can have [53-55], it gives 
only a snapshot of the complex life cycle of the protein.  
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Figure 1.7 Timescale range of dynamic events in enzymes. Adapted from Boehr et al. [56]. 
 
Ensemble FRET has been used extensively to measure static distances in the range of 10-
100 Å [57-60]. However, ensemble measurements record only the average responses, and rare 
events usually escape notice because they are buried in the average properties of the system. 
The first reported observation of FRET between a single donor and a single acceptor 
fluorophore [61] pointed out the potential of the single-molecule techniques and motivated 
further developments towards biological applications. The technique can now be used to study 
intramolecular conformational changes, when both fluorophores are attached to the same 
molecule, or intermolecular interactions, when two fluorophores are attached to different 
molecules. Intramolecular labeling can provide information about enzyme structural changes 
during catalysis, folding/unfolding of macromolecules as well as fluctuation and stability of 
macromolecules.  
Single-molecule FRET can be observed in two different experimental setups: surface 
immobilization or free diffusion through the solution. Immobilized molecules can be observed 
for longer periods of time, providing information about several reaction cycles, but the 
proximity of the surface can cause artifacts. Molecules freely diffusing through the solution 
can be observed only for a short period of time while traveling through the observation 
volume (Figure 1.8), but this setup excludes surface artifacts, and can provide information 
about diffusion properties.  
 
 
Figure 1.8 Single molecule diffusing through the optically defined observation volume. 
Fluorescent molecules cause a rise of the detected fluorescent signal while passing through the 
observation volume. 
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Many of the molecular machines essential for cell function and survival have complex kinetic 
pathways and intermediates, and also consist of several interacting components. The ability of 
different single-molecule techniques to follow structural dynamics of macromolecules is 
proving to be important for studies of many important processes (e.g. protein folding, 
replication, transcription). Although recent advances in single-molecule fluorescence 
spectroscopy allow for real-time observations of conformational changes on biologically 
relevant timescales [40, 43, 45, 62-65, and reviewed in 66], all experiments are performed 
under in vitro conditions. The real challenge will be to measure conformational dynamics in 
vivo, which will enable the studies of enzymes and multicomponent molecular machines in 
their natural environment.  
 
1.6. Aim 
 
The most striking feature of the restriction enzyme BsoBI is the complete encirclement of 
specific DNA inside the tunnel formed by two protein subunits. The gap between subunits is 
too small to allow DNA entry, and large conformational changes during substrate binding 
were suggested. The main goal of this study was to determine the nature and dynamics of 
these conformational changes. For this purpose, a set of single-cysteine variants had to be 
created, and labeled with different fluorescent dyes, and the ability of fluorescence resonance 
energy transfer (FRET) to monitor distance changes of biomolecules was used. The 
combination of the results obtained from different fluorescent techniques (ensemble steady-
state and pre-steady state, as well as single molecule techniques) will allow the description of 
the catalytic cycle of BsoBI as well as the dynamics of this process.  
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2. Materials and methods 
 
2.1. Materials 
 
2.1.1. Chemicals and biochemicals 
 
All chemicals and biochemicals used were of high purity grade and are listed in Table 1. All 
buffers were prepared using water from the Milli-Q Synthesis (Millipore) water purification 
system. 
 
Table 1 
Chemical Company 
Acetic acid Roth 
40% Acrylamide:bisacrylamide solution29:1 AppliChem 
40% Acrylamide:bisacrylamide solution19:1 AppliChem 
Agar AppliChem 
Agarose Ultra Pure TM Invitrogen 
Ammoniumpersulfate Merck 
Ampicillin AppliChem 
[α-32P] dATP Hartmann Analytic 
[γ-32P] ATP Hartmann Analytic 
Boric acid Merck 
Bromphenol blue Merck 
BSA NEB 
Calcium chloride Merck 
κ-Casein AppliChem 
Chloramphenicol AppliChem 
Coomassie® Brilliant blue G250 AppliChem 
DTT AppliChem 
EDTA AppliChem 
Ethanol Merck 
Ethidium bromide Roth 
Formamide Merck 
Glycerol AppliChem 
Glycine Merck 
Imidazole Merck 
IPTG AppliChem 
Lubrol Sigma 
Magnesium chloride Merck 
2-Mercaptoethanol Merck 
Ni2+-NTA-agarose Qiagen 
Poly(dI-dC) GE Healthcare 
Potassium chloride Merck 
Potassium dihydrogen phosphate Merck 
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di-Potassium hydrogen phosphate Merck 
Sodium chloride Merck 
SDS AppliChem 
TCEP Pierce 
TEMED Merck 
Tris Merck 
Tryptone AppliChem 
Urea AppliChem 
Yeast extract AppliChem 
 
2.1.2. Plasmids 
 
The gene for the BsoBI wild type enzyme (see Supplementary information for the sequences), 
with a His-tag on the N-terminus (5 histidines), was cloned into the pQE2 vector (Qiagen). 
This newly created pQE2-HisBsoBI plasmid was used to produce the cysteine free variant, 
where 3 cysteines, C214, C218 and C317, were exchanged to alanine, serine and alanine, 
respectively, and thereby the pQE2-HisBsoBI-cf plasmid was created. This plasmid was used 
for producing different single-cysteine variants. 
Plasmid pACYC M.BsoBI codes for the BsoBI methyltransferase, and protects the host 
genome from BsoBI cleavage.  
For activity assays, two different plasmids were used: pAT153 triple, which contains two 
BsoBI recognition sites, and pDGS, which contains one BsoBI recognition site. 
 
2.1.3. Bacterial strains 
 
The E. coli K12 strain XL1-Blue MRF’ (Stratagene Europe) was used for expression of 
different BsoBI variants. The genotype of this strain is: Δ(mcrA)183 Δ(mcrCB-hsdSMR-
mrr)173 endA1 supE44 thi-1 recA1 gyrA96 relA1 lac [F´proAB lacIqZΔM15 Tn10 (Tetr)]. 
The E. coli strain DH5α was used for amplification of the plasmid pAT153 triple. The E. coli 
strain XL1-Blue was used for amplification of the plasmid pDGS.  
 
2.1.4. Buffers 
 
Buffers used for protein purification (chapter 2.2.3.4.) were: 
Digest buffer: 10 mM Tris-HCl pH 8.0, 500 mM NaCl, 15 mM imidazole, 0.5 mM EDTA 
Washing buffer: 10 mM Tris-HCl pH 8.0, 200 mM NaCl, 15 mM imidazole, 0.5 mM EDTA 
Elution buffer: 10 mM Tris-HCl pH 8.0, 200 mM NaCl, 200 mM imidazole, 0.5 mM EDTA 
Dialysis buffer: 30 mM KPi pH 7.2, 0.5 mM EDTA, 0.1 mM 2-mercaptoethanol, 0.01 % 
(w/v) lubrol, 300 mM NaCl, 50 % glycerol 
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The cleavage buffer used for activity assays was: 10 mM Tris-HCl, 50 mM NaCl, 10 mM 
MgCl2, pH 7.9. For binding assays, MgCl2 in the cleavage buffer was replaced by CaCl2 
(supports specific binding, but not cleavage of DNA substrate). 
 
Buffers used for FPLC purification of labeled proteins (chapter 2.2.5.2.) were: 
Start buffer: 20 mM KH2PO4, 20 mM K2HPO4, pH 8.0 
Elution buffer: 20 mM KH2PO4, 20 mM K2HPO4, 500 mM KCl, pH 8.0 
 
Buffers used for steady state, stopped-flow and single molecule experiments were: 
CaCl2 buffer: 10 mM Tris-HCl pH 7.9, 50 mM NaCl, 5.5 mM CaCl2 
MgCl2 buffer: 10 mM Tris-HCl pH 7.9, 50 mM NaCl, 5.5 mM MgCl2 
EDTA buffer: 10 mM Tris-HCl pH 7.9, 50 mM NaCl, 0.5 mM EDTA 
 
2.1.5. Enzymes 
 
Several restriction enzymes were used, and they are listed alphabetically in Table 2. 
 
Table 2 
Name Recognition sequence Company 
AclI 5' - A A ^ C G T T - 3' NEB 
BsaI 5' - G G T C T C (N)1^ - 3' NEB 
3' - C C A G A G (N)5^ - 5' 
BsrDI 5' - G C A A T G N N ^ - 3' NEB 
3' - C G T T A C ^ N N - 5' 
DpnI 3‘ - G A* ^ T C – 5‘ Fermentas 
NaeI 5' - G C C ^ G G C - 3' NEB 
NdeI 5' - C A ^ T A T G - 3' NEB 
PstI 5' - C T G C A ^ G - 3' Fermentas 
SphI 5' - G C A T G ^ C - 3' Fermentas 
^ represents cleavage position; N: A, C, T or G; * methylation site 
 
DNA modification enzymes are listed in Table 3. 
 
Table 3 
Name Company 
Taq DNA polymerase Overexpressed and purified in our institute 
Pfu DNA polymerase Overexpressed and purified in our institute 
T4 Polynucleotide kinase Fermentas 
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2.1.6. Markers 
 
Weight markers used for protein and DNA gels are listed in Table 4. 
 
Table 4 
Name Company 
PageRulerTM Unstained protein ladder Fermentas 
GeneRulerTM 1kb Fermentas 
pUC Mix marker, 8 Fermentas 
 
2.1.7. Fluorophores 
 
For labeling of single-cysteine BsoBI variants, Alexa fluorophores, with a maleimide 
functional group were used: Alexa488 C5 maleimide, Alexa594 C5 maleimide and Alexa647 
C2 maleimide (Figure 2.1). All fluorophores used were purchased from Invitrogen. 
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Figure 2.1 Alexa fluorophores  
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2.2. Methods 
 
2.2.1. Microbiological methods 
 
2.2.1.1. Culture media 
 
LB (Luria Bertani) medium was used for all bacterial cell growth.  
LB medium: 10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl 
For making the agar plates, 1.5 % (w/v) of bacto-agar was added to the liquid medium. 
Antibiotics were added to the media after sterilization, shortly before use. 
 
2.2.1.2. Preparation of electrocompetent cells 
 
500 ml of LB medium was inoculated with 10 ml of an overnight E. coli culture, and grown at 
37 °C until an OD600 of 0.6-0.8 was reached. The culture was incubated on ice for 15 min and 
then centrifuged for 15 min at 4200 rpm, 4 °C (Beckman, J6-HC). The cell pellet was washed 
three times with ice cold 10 % (v/v) glycerol solution (250 ml, 150 ml and 20 ml, 
consecutively). After the last step of centrifugation, the cell pellet was resuspend in 2 ml of 
10 % glycerol. The cells were separated into 80 μl aliquots, rapidly frozen in liquid nitrogen 
and stored at -80 °C.  
 
2.2.1.3. Electroporation 
 
Aliquots of frozen electrocompetent cells and plasmid for transformation were thawed on ice. 
The electroporation cuvette was cooled on ice. 4-10 ng of plasmid was mixed with an aliquot 
(80 μl) of electrocompetent cells, and incubated on ice for 5 minutes. The mixture was 
transferred into the cuvette, and electroporation was done in the electroporator (EasyjecT, 
EquiBio), with 1250 V, 25 mA and 25 ohm. The cells were immediately transferred into 
900 μl of LB medium, and incubated at 37 °C for 1 h. After the incubation, 10-40 μl of cells 
was spread on an agar plate containing the necessary antibiotic, and the plate was incubated 
o/n at 37 °C until colonies were grown. Afterwards, the plate was kept at 4 °C.  
 
2.2.2. Molecular biology methods 
 
2.2.2.1. Electrophoresis 
 
Characterization and analysis of different protein and DNA molecules was done using 
different electrophoresis techniques. 
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 2.2.2.1.1. SDS-PAGE 
 
Analysis and characterization of proteins were done using SDS-PAGE. The SDS-
Polyacrylamide gel contained a stacking and a resolving gel. Stacking and resolving gels 
differ in polyacrylamide content (6 % stacking gel, 12 % resolving gel), and pH value (pH 6.8 
stacking gel, pH 8.8 resolving gel). Protein samples were mixed with 0.2 x vol of 5 x 
concentrated loading buffer (160 mM Tris-HCl pH 6.8, 2 % (w/v) SDS, 5 % (v/v) 2-
mercaptoethanol, 40 % (v/v) glycerol, 0.1 % (w/v) bromphenol blue) and loaded on the gel. 
The electrophoretic separation was done at 35 mA for approximately 1 h, in 1 x SDS buffer 
(25 mM Tris, 190 mM glycine, 0.1 % (w/v) SDS). After completion of the run, gels were 
washed 3x10 minutes with hot water, and then stained using the Coomassie Brilliant Blue 
staining solution (0.1 % (w/v) Coomassie Brilliant Blue G-250, 2 % (v/v) H3PO4, 5 % (w/v) 
Al2O3, 10 % (v/v) ethanol). Protein bands were visualized and documented using the gel 
documentation system BioDocAnalyze (Biometra).  
 
 2.2.2.1.2. Polyacrylamide gel electrophoresis 
 
PCR products and smaller DNA fragments were analyzed using polyacrylamide gel 
electrophoresis. The gel contained 6 % polyacrylamide in 1 x TPE pH 8.2 (90 mM Tris-
H3PO4, 2 mM EDTA), and the separation was done in 1 x TPE at 30 mA for approximately 
1 h. DNA bands were stained using ethidium bromide, and visualized and documented using 
the gel documentation system BioDocAnalyze (Biometra).  
 
 2.2.2.1.3. Agarose gel electrophoresis 
 
Analysis of plasmid DNA was done using agarose gel electrophoresis. The gel contained 
0.8 % (w/v) agarose in 1 x TBE pH 8.3 (100 mM Tris-HCl, 100 mM H3BO3, 2.5 mM EDTA), 
and the separation was done in 1 x TBE at 90 V for approximately 1 h. DNA bands were 
stained using ethidium bromide, and visualized and documented using the gel documentation 
system BioDocAnalyze (Biometra).  
 
 2.2.2.1.4. EMSA 
 
EMSA was used to determine binding activity of unlabeled and labeled BsoBI variants. The 
gel contained 6 % polyacrylamide in 20 mM Tris-Acetate pH 8.2, 5 mM CaCl2, and the 
separation was done in 20 mM Tris-Acetate pH 8.2, 5 mM CaCl2. Before loading the samples, 
the gel was prerun for 30’ at 80 V, and after the loading separation was done for 
approximately 2 h.  
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 2.2.2.1.5. Denaturing polyacrylamide gel electrophoresis 
 
For analyzing short oligonucleotides, products of BsoBI cleavage, denaturing polyacrylamide 
gels were used. These gels contain 7 M urea, and allow for separation of single DNA strands. 
In order to separate products of 39 bp oligonucleotide cleavage, 15 % gels were prepared, 
using the acrylamide:bis-acrylamide mix 19:1, in 1 x TBE buffer, with addition of 7 M urea. 
The mixture was heated for a few seconds in a microwave oven to dissolve urea, and then 
cooled down before adding APS and TEMED. The gels were prerun for 15’ at 15 mA, and the 
separation of samples was done at the same current. This allowed for warming the gels while 
running, which, in addition to urea, helps denaturing the DNA. The samples were mixed in a 
1:1 ratio with loading buffer containing 90 % (v/v) formamide diluted in 10 x TBE buffer. 
After mixing with loading buffer, tubes were heated up for 1’ at 95 °C to denature the DNA, 
and then placed on ice to prevent reannealing.  
 
2.2.2.2. Isolation of DNA 
 
 2.2.2.2.1. Minipreparation 
 
Isolation of plasmids containing genes for different BsoBI variants was done using the 
commercially available QIAprep Spin Miniprep Kit (Qiagen), following the manufacturer’s 
instructions.  
 
 2.2.2.2.2. Midipreparation 
 
Isolation of plasmids used for cleavage assays (pAT153 triple, pDGS) was done using the 
commercially available QIAGEN Plasmid Midi Kit (Qiagen), following the manufacturer’s 
instructions.  
 
 2.2.2.2.3. PCR purification 
 
Purification of PCR fragments used for EMSA and site-directed mutagenesis was done using 
the commercially available QIAquick PCR Purification Kit (Qiagen).  
 
2.2.3. Creating single-cysteine BsoBI variants 
 
2.2.3.1. Site-directed mutagenesis 
 
For creating different single-cysteine variants, the plasmid pQE2-HisBsoBI-cf was used as 
template, and primers were constructed to carry the desired mutation and an additional 
restriction enzyme recognition site. The list of primers used is presented in Table 12. PCR 
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was done with Pfu polymerase, and the program was: one-time denaturation at 95 °C 3 min, 
30 cycles of denaturation (95 °C, 30 sec), annealing (58 °C, 30 sec) and elongation (68 °C, 
90 sec), and final elongation 68 °C, 3 min. PCR fragments (ca. 300 bp long, so-called 
“megaprimers” [67]) were purified and used in a second PCR reaction, called “rolling circle” 
PCR, as primers (the template plasmid was the same). The program for this PCR reaction 
was: one-time denaturation at 93 °C, 5 min, 9 cycles of denaturation (93 °C, 1 min), annealing 
(60 °C, 50 sec) and elongation (68 °C, 15 min), and final elongation 68 °C, 20 min.  
The “rolling circle” PCR product was digested with DpnI, which only cleaves the methylated 
template plasmid, lacking the mutation. The digested sample (in volume V) was precipitated 
on ice using the following procedure: 1/3 V 3 M NaOAc and 3 V 100 % (v/v) ethanol were 
added to precipitate DNA. The sample was then centrifuged at 13000 x g, 30 min, at 4 °C, and 
the precipitate was washed with 6 V of 70 % (v/v) ethanol. After drying, the precipitated 
plasmid was resuspended in water. The electrocompetent cells were transformed with this 
plasmid, and plated on agar plate containing ampicillin and chloramphenicol.  
 
2.2.3.2. Screening 
 
The clones obtained after mutagenesis were screened for the presence of the desired 
mutation(s). For each mutation 10 clones were picked, and PCR was performed to amplify the 
region with the putative mutation (using Taq polymerase), also containing the newly 
introduced recognition site for the selected marker enzyme. The PCR program was: one-time 
denaturation at 95 °C, 3 min, 30 cycles of denaturation (93 °C, 30 sec), annealing (52 °C, 
30 sec) and elongation (72 °C, 90 sec), and final elongation 72 °C, 3 min. Primers used are 
listed in Table 14. PCR fragments were incubated with corresponding marker enzymes, and 
products of these reactions were analyzed on polyacrylamide gels (Chapter 2.2.2.1.2.).  
Positive clones were selected, grown in liquid culture, plasmids were isolated using 
minipreparation, and sequenced to verify that the desired mutation was present and that the 
rest of the coding sequence for BsoBI does not contain any additional mutations. 
 
2.2.3.3. Overexpression of BsoBI 
 
Freshly transformed E. coli cells, containing the plasmid coding for BsoBI, were plated on an 
agar plate, and the plate was incubated at 37 °C until colonies had grown. A single colony 
was picked and a 25 ml liquid culture (containing Amp and Chl) was inoculated and 
incubated o/n at 37 °C in an air shaker. The 500 ml liquid culture was inoculated with 10-
15 ml of this preculture, and the cells were grown under the same conditions until an OD600 of 
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0.7-0.9. The induction was started by adding IPTG to a final concentration of 1 mM, and the 
cells were grown at 37 °C for 2 h.  
An aliquot of cells (1 ml) was collected before induction and 2 h after induction, and used to 
check the expression. The cells were harvested by a 1 min centrifugation (Eppendorf 
MiniSpin®), the pellet was resuspended in 30 μl of loading buffer, heated up to 95 °C for 
10 min, and loaded onto an SDS gel. Based on OD600 measurements of samples before and 
after induction, the same amount of cells was loaded, allowing for comparison of BsoBI 
expression.  
After 2 h of induction, the cells were harvested by a 15 min centrifugation at 4200 rpm, 4 °C 
(Beckman, J6-HC). The pellet was washed with 40 ml of STE buffer (100 mM NaCl, 10 mM 
Tris-HCl pH 8.0, 0.1 mM EDTA), and centrifuged again as described above. The pellet was 
stored at -20 °C or resuspended in digest buffer immediately for further steps of protein 
purification.  
 
2.2.3.4. Purification of BsoBI 
 
The cell pellet was thawed on ice and resuspended in 10 ml of digest buffer. The cells were 
transferred to a 25 ml beaker, and lysed by ultrasonification using a Branson sonifier 
(6 x 1 min, with 30 sec break, duty cycle 50 %, output control 5). The soluble fraction 
containing proteins was separated from cell debris by a 30 min centrifugation at 20000 rpm, 
4 °C (Beckman, JA20).  
All BsoBI variants used contain a His-tag which is used for reversible binding of the protein 
to Ni-NTA agarose via the imidazole group of the histidines. For this purpose, the 
resuspended volume of 500 μl of Ni-NTA was equilibrated with 10 ml of digest buffer. The 
supernatant containing BsoBI was added to the Ni-NTA agarose matrix, and incubated at 4 °C 
for 1 h. This was followed by the wash, twice with digest buffer (2 x 10 ml) and twice with 
wash buffer (2 x 10 ml). The protein was eluted with 2 ml of elution buffer and 4 fractions of 
500 μl each were collected. Fractions containing protein were dialyzed o/n in the dialysis 
buffer at 4 °C, and stored at -20 °C.  
 
2.2.3.5. Determination of protein concentration 
 
Protein concentration was measured using the spectrophotometer NanoDrop® 1000 (Thermo 
Scientific), using the equation: A = εcl, where A is the absorbance at 280 nm, ε is the 
extinction coefficient (49620 M-1cm-1 for BsoBI variants), c is the concentration (in M) and l 
is the length of the light pathway.  
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2.2.3.6. Determination of protein binding and cleavage activity 
 
2.2.3.6.1. Determination of binding activity 
 
The binding activity of purified BsoBI variants was determined using EMSA. PCR fragments 
(237 bp) used to test binding activity were prepared using the primers listed in Table 13 and 
plasmid pAT153 triple as template. The PCR program was: one-time denaturation at 95 °C, 
3 min, 30 cycles of denaturation (93 °C, 30 sec), annealing (52 °C, 30 sec) and elongation 
(72 °C, 90 sec), and final elongation 72 °C, 3 min. To achieve radioactive labeling of PCR 
fragments, [α-32P] dATP (with specific activity of 5000 Ci/mmol) was added to the reaction, 
to a final concentration of 0.04 μM. PCR products were purified as described in Chapter 
2.2.2.2.3. and the concentration was determined by the UV-absorption at 280 nm using a UV 
spectrophotometer (U-3000 Spectrophotometer, Hitachi).  
Protein concentrations used in the binding reaction were: 8 nM, 12 nM, 20 nM, 31 nM, 
50 nM, 79 nM, 125 nM, 197 nM, 312 nM and 494 nM, while DNA concentration was 1 nM. 
The binding reaction was carried out at room temperature for 15 min, in binding buffer 
(Chapter 2.1.4.), with the addition of 1 μg Poly(dI-dC)·Poly(dI-dC) (GE Healthcare) as 
polynucleotide that blocks nonspecific binding. DNA fragments were analyzed on 
polyacrylamide gels, as described in Chapter 2.2.2.1.4. The amounts of bound and free DNA 
were determined using an Instant Imager (Packard).  
 
2.2.3.6.2. Determination of cleavage activity 
 
Purified BsoBI variants were incubated with pAT153 triple or pDGS plasmids at 37 °C for 
1 h in cleavage buffer (with addition of 1 x BSA), to determine cleavage activity. Protein 
concentrations were: 195 pM, 390 pM, 780 pM, 1.56 nM, 3.125 nM, 6.25 nM, 12.5 nM, 
25 nM, 50 nM and 100 nM, while DNA concentration was 6 nM (100 ng). After the reaction 
was completed, DNA fragments were analyzed on a 0.8 % agarose gel (2.2.2.1.3.).  
 
2.2.4. Michaelis-Menten kinetics 
 
Michaelis-Menten kinetics describe the rates of enzyme catalysed reactions. The equation 
represents the relation between the initial reaction rate (V0) and the substrate concentration 
([S]): 
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Where V0 is the initial velocity, Vmax is the maximum velocity, [S] is the substrate 
concentration and KM is the Michaelis constant, which represents the substrate concentration 
at which the velocity reaches its half maximum, and it is a measure of the affinity of an 
enzyme for the substrate. The resulting graph is a hyperbola, which asymptotically 
approaches the maximum velocity (Vmax). 
The substrate for determining the cleavage rates was a 39 bp long oligonucleotide, 5’ labeled 
with radioactive phosphorus 32P. The labeling reaction was done following the protocol for 
labeling of 5’ termini of DNA (available on www.fermentas.com) using T4 polynucleotide 
kinase (T4 PNK; Fermentas). Both strands of the oligonucleotide were labeled. The excess of 
free [γ-32P] ATP was removed using Illustra MicroSpinTM G-25 columns (GE Healthcare).  
Initial rates were determined at three different temperatures: room temperature (25 °C), 37 °C 
and 65 °C. The protein concentration for experiments at room temperature was 100 pM, and 
DNA concentrations were 100 pM, 500 pM, 1000 pM, 5000 pM, 10000 pM, 15000 pM, 
20000 pM and 25000 pM. For the experiments at 37 °C, the protein concentration was 10 pM, 
while the DNA concentrations were 100 pM, 200 pM, 500 pM, 1000 pM, 1500 pM, 2000 pM, 
5000 pM and 10000 pM. Since BsoBI has the highest activity at 65 °C, the protein 
concentration for experiments at this temperature had to be lowered to 1 pM, and DNA 
concentrations used were 10 pM, 20 pM, 50 pM, 100 pM, 200 pM, 500 pM, 1000 pM and 
2000 pM. In order to have the same radioactivity in all reactions, concentration of radioactive 
DNA was always 100 pM, and it was mixed with nonradioactive DNA (of the same sequence) 
to achieve the desired concentration. When DNA concentration was lower than 100 pM, only 
radioactive DNA was used, without mixing with nonradioactive DNA. Protein was diluted in 
cleavage buffer with the addition of 20 % (v/v) glycerol, to prevent adsorption to the tube 
walls.  
First, the master mix containing cleavage buffer and DNA was prepared, and then the reaction 
was started by adding BsoBI. At time points 10 s, 30 s, 1 min, 2 min, 3 min, 5 min, 7 min and 
10 min, 10 μl were taken, mixed with loading buffer and put on 95 °C for 1 min. The samples 
were loaded onto 15 % denaturing polyacrylamide gels. The amounts of cleaved and 
uncleaved DNA were determined using an Instant Imager (Packard).  
 
2.2.5. Site-specific fluorescent labeling of single-cysteine variants 
 
The most specific method for protein modification is the use of cysteine, through the 
nucleophilic attack of the maleimide group to the cysteine’s sulfhydryl group (Figure 2.2). For 
 Materials and methods | 32  
 
this purpose, the cysteines positioned on the surface of the protein have to be replaced by 
mutagenesis, and the desired position to be labeled must be changed to cysteine.  
 
NR1
O
O
+ R2 SH NR1
O
O
H
S R2
 
Figure 2.2 Chemical modification reaction of sulfhydryl with maleimide. R1 – fluorophore 
attached to maleimide, R2 – polypeptide chain containing a free sulfhydryl group of cysteine. 
The result of the nucleophilic attack is a fluorophore covalently attached to the cysteine residue 
of the protein. 
 
To achieve complete labeling with fluorophore, cysteine introduced at the desired position 
must be kept in the reduced state. This was accomplished by incubation of protein with TCEP 
(tris(2-carboxyethyl) phosphine) for 10 min prior to the labeling reaction (Figure 2.3). TCEP 
is a reducing agent which is used instead of other reducing agents (like DTT or 2-
mercaptoethanol) because of the advantage that it does not have to be removed before the 
labeling, since it does not react with maleimides. Also, the highest stability of maleimide 
groups is at pH 7.2, so the labeling reactions are usually done at this pH value.  
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Figure 2.3 TCEP reaction. 
 
 
2.2.5.1. Labeling and purification of proteins used in steady-state and stopped-flow 
experiments 
 
Purified protein stored in buffer containing 2-mercaptoethanol (2-ME) was loaded onto a 
HiTrapTM Desalting column (GE Healthcare) connected to the ÄKTApurifierTM (GE 
Healthcare), to remove 2-ME and bring the protein into the buffer suitable for labeling. The 
list of buffers used is presented in Chapter 2.1.4. Chromatography steps are presented in Table 
5.  
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Table 5 
Equilibration 1 CV 
Elution 3 CV 
Concentration 1.3 % B 
Fraction size 0.5 ml 
Flow rate 0.8 ml/min 
CV: column volume; % B: concentration of elution buffer 
 
After removing 2-ME, the protein was incubated with a mixture of donor (Alexa488) and 
acceptor (Alexa594 or Alexa647) fluorophores (Chapter 2.1.7). The concentration of the 
donor fluorophore was in 1-fold molar excess over dimer protein, and acceptor fluorophore in 
10-fold molar excess. The labeling reaction was done at room temperature for 30 min. The 
result of this labeling procedure is the dimer protein labeled randomly with donor and 
acceptor fluorophores on two cysteines. The excess of unreacted fluorophore was removed 
using a HiTrapTM Desalting column, as previously described. Protein was labeled the same 
way using only donor fluorophore in excess, for use in control experiments. Labeled protein 
was dialysed o/n against storage buffer containing glycerol, and kept at -20 °C.  
 
2.2.5.2. Labeling and purification of proteins used in single-molecule experiments 
 
In order to obtain protein labeled with one donor fluorophore on one cysteine of the dimer, 
and one acceptor fluorophore on the other one, a different labeling and purification protocol 
was used. First, 2-ME was removed from the protein preparation as described in Chapter 
2.2.5.1. Then, the protein was labeled with donor fluorophore in a 1-fold molar excess over 
dimer, and unreacted dye was removed as previously described. Donor labeled protein was 
then loaded onto a ResourceQTM column (GE Healthcare). The ResourceQ column is an anion 
exchange column, which enables separation of species according to their charge. Alexa 
fluorophores are negatively charged, and this property can be used to separate unlabeled, 
single labeled and double labeled protein. Chromatography steps are presented in Table 6, and 
concentration gradient in Figure 2.4.  
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Table 6 
Equilibration  5 CV 
Wash column 2 CV 
Gradient segment 1 20 % B 
      Length of gradient 2 CV 
Gradient segment 2 30 % B 
      Length of gradient 15 CV 
Gradient segment 3 100 % B 
      Length of gradient 2 CV 
Gradient delay 2 CV 
Fraction size 1 ml 
Flow rate 1 ml/min 
CV: column volume; % B: concentration of elution buffer 
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Figure 2.4 Concentration gradient used for separation with ResourceQTM. CV: column 
volume, % B: concentration of elution buffer; A – column equilibration, B – sample loading, C 
– column washing, D – gradient segment 1, E – gradient segment 2, F – gradient segment 3, G 
– gradient delay 
 
The order of elution from the ResourceQ column is: unlabeled protein, single labeled protein 
(one donor fluorophore on one cysteine) and double labeled protein (two donor fluorophores 
on two cysteines). The fraction (1 ml) containing single labeled protein was collected, 200 μl 
was kept as donor only sample, and the rest was labeled with 10-fold molar excess of acceptor 
fluorophore. Unreacted acceptor dye was removed as described previously using a desalting 
column. Labeled protein was dialysed o/n into storage buffer containing glycerol, and kept at 
-20 °C.  
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2.2.5.3. Determination of labeling efficiency 
 
The protein and the fluorophore concentration after labeling was determined by recording the 
absorbance spectrum between 220 nm and 750 nm using the spectrophotometer 
NanoDrop® 1000. Alexa fluorophores absorb also at 280 nm, so the protein concentration has 
to be calculated using specific correction factors. Correction factors for fluorophores used 
were provided by the supplier: Alexa488 0.11, Alexa594 0.56, Alexa647 0.03. The degree of 
labeling was calculated using the following equation: 
 
Where Amax is the absorbance of the fluorophore, εprot is the extinction coefficient of the 
protein, A280 is the absorbance of the protein, CF is the fluorophore correction factor and εmax 
is the extinction coefficient of the fluorophore.  
 
2.2.5.4. Determination of binding and cleavage activity 
 
Binding and cleavage activity of all labeled proteins were determined as described in Chapter 
2.2.3.6.  
 
2.2.6. Fluorescence methods 
 
2.2.6.1. Introduction to fluorescence 
 
Luminescence is the optical phenomenon of emitting light after any type of excitation other 
than increasing the temperature. It can be divided into two categories, fluorescence and 
phosphorescence. During fluorescence, the substance absorbs a photon of high energy (lower 
wavelength), and emits a photon of lower energy (higher wavelength). The phenomenon of 
different wavelengths of absorption and emission was observed by George G. Stokes in 1852, 
and is now called Stokes shift. The electron in the excited state is paired with the electron in 
the ground state (by opposite spin), and this excited state is called excited singlet state. The 
return of the excited electron to the ground level is therefore spin allowed, and occurs rapidly 
(typically 108 s-1). If the excited electron has the same spin as the ground state electron (triplet 
excited state), the return to the ground state is forbidden and therefore slower (103 to 10 s-1). 
This phenomenon is called phosphorescence. Different electronic states and transitions 
between the absorption and emission of photons are represented in the Jablonski diagram 
(Figure 2.5) [41]. 
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Figure 2.5 Jablonski diagram. S0 – singlet ground state, S1, S2 – singlet excited states, T1 – 
triplet excited state, v.r. – vibrational relaxation (10-14 – 10-11 s), i.c. – internal conversion (10-14 
– 10-11 s), is.c. intersystem crossing,  A – absorbance (10-1 5 s), F – fluorescence (10-9 – 10-7 s), P 
– phosphorescence (10-3 – 102 s) 
 
2.2.6.2. Fluorescence Resonance Energy Transfer (FRET) 
 
FRET is the process that occurs when the emission spectrum of one fluorophore (called 
donor) overlaps with the absorption spectrum of another fluorophore (called acceptor) [Figure 
2.6], and when two fluorophores are in close proximity.  
 
 
Figure 2.6 Spectral overlap [J(λ)] between donor emission spectrum and acceptor 
absorption spectrum 
 
During FRET, donor and acceptor fluorophores are coupled by dipole-dipole interaction, and 
there is no photon transferred between the two fluorophores (Figure 2.5). The efficiency of 
energy transfer is determined by the spectral overlap and the distance between the donor and 
acceptor, and it is also dependent on the Förster distance. The Förster distance is defined as 
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the distance between two fluorophores when the energy efficiency is 50 %. The graphical 
relationship between fluorophore distance and FRET efficiency is presented in Figure 2.7. 
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Figure 2.7 FRET efficiency (E) as a function of distance (r). R0 – Förster distance 
 
R0 is characteristic for each fluorophore pair, and can be determined using the following 
equation: 
 
Where κ2 is the orientation factor between the dipoles of donor and acceptor, n is the 
refractive index of the medium, ΦD is the quantum yield of the donor and J(λ) is the spectral 
overlap. The value of the orientation factor κ2 is usually taken as 2/3, which assumes freely 
rotating donor and acceptor fluorophores. However, depending on the relative orientation of 
donor and acceptor, this factor can vary from 0 to 4. If the dipoles are in a head-to-tail parallel 
orientation κ2 is 4, and if they are parallel κ2 is 1. The variation from 1 to 4 would result in 
only 26 % change in R0, since the sixth root is taken to calculate it. If the dipoles are 
perpendicular to one another κ2 has the value 0, and the error would be much higher. By 
measuring the fluorescence anisotropy of donor and acceptor, which gives the information of 
their mobility, the errors in κ2 values can be minimized.  
The FRET efficiency was calculated using the method of Clegg [68]. For this purpose, the 
fluorescence of donor only labeled protein, and donor-acceptor labeled protein was measured, 
by exciting at the wavelength of 470 nm, and recording the emission from 490 nm to 700 nm. 
Then, the spectrum of donor only labeled protein was normalized to the maximum of donor 
fluorescence, and subtracted from the spectrum of double labeled protein. As the result, the 
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acceptor fluorescence, without donor fluorescence, is obtained. An example of different 
spectra is presented in Figure 2.8. 
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Figure 2.8 Calculation of FRET efficiency. Fluorescence spectra of donor only sample (green 
line), donor/acceptor sample (blue line) and calculated “pure” acceptor spectrum (red line) 
 
The FRET efficiency (E) can be calculated using the following equation: 
 
 
 
Where F*A,FRET is the corrected (“pure”) acceptor fluorescence in the donor/acceptor sample, 
FA/dir is the acceptor fluorescence in the donor/acceptor labeled sample, εA and εD are the 
extinction coefficients of acceptor and donor, respectively, at the wavelengths chosen, d is the 
degree of labeling, and c and cA are concentrations of donor and acceptor fluorophores, 
respectively. λex and λem of donor (D) and acceptor (A) represent maxima of the excitation and 
emission spectra, respectively. Assuming that the extinction coefficient of the acceptor is 0 at 
the donor excitation maximum, the ratio εA(λexD)/εA(λexA) will have the value of 0, and can be 
omitted from the equation.  
 
2.2.6.3. Steady-state ensemble FRET experiments 
 
To analyze conformational changes in BsoBI upon DNA binding, steady-state ensemble 
measurements were carried out. The measurements were done in the FluoroMax®4 
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spectrofluorimeter (HORIBA Jobin-Yvon). For this purpose, the protein was labeled with 
Alexa488 fluorophore as donor and Alexa594 as acceptor, as described in chapter 2.2.5.1. 
Labeled protein was diluted to 50 nM dimer concentration, in appropriate buffer (chapter 
2.1.4.), and fluorescence spectra were measured after excitation at 470 nm for Alexa488, and 
575 nm for Alexa594. The emission of Alexa488 (in donor and donor/acceptor labeled 
sample) was monitored between 490 nm and 800 nm, while emission of Alexa594 was 
monitored between 595 nm and 800 nm. The excitation and emission slits were set at 2.5 nm, 
and spectra were corrected using the correction function provided by the spectrofluorimeter 
supplier. After recording the spectrum of protein alone, an excess of specific or unspecific 
DNA was added to the cuvette (Quartz Ultra-Micro Cell, Hellma), and the measurements 
were repeated.  
 
2.2.6.4. Fluorescence stopped-flow experiments 
 
In order to monitor fast reaction of DNA binding by BsoBI, starting from the moment of 
mixing, stopped-flow measurements were performed, using the SFM-300 stopped-flow 
instrument (Bio-Logic). The scheme of the instrument is shown in Figure 2.9. Main parts of 
the apparatus are: two syringes (containing the reaction species) driven by the motor, mixing 
device, observation cell, stopping syringe and detection system capable of rapid response. 
Two reaction species are added to different syringes, and the reaction is started by pushing the 
same volume of reactants from both syringes at the same time. The reactants are kept in the 
observation cell through a stop syringe, and excited by appropriate wavelength. The emission 
is measured and recorded, with a short delay (dead time) between the mixing and detection, 
which is in the order of ms.  
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Figure 2.9 Stopped-flow instrument scheme. Explanation in the text. 
 
The excitation wavelength used was 436 nm. At this wavelength, the lamp has a maximum 
energy output. The change in fluorescence signal was monitored using emission filters 
specific for donor or acceptor fluorophore. Bandpass filter D515/30m (LOT Oriel) was used 
for Alexa488 (central wavelength 515 nm, bandwidth 30 nm) and D630/30m (LOT Oriel) was 
used for Alexa594 (central wavelength 630 nm, bandwidth 30 nm). For all measurements, 
100 μl of each reactant were mixed, and 10-20 curves were collected and averaged using 
Biokine 2.07 software. The fitting was done using Dynafit program (BioKin) [69]. All 
measurements were done at room temperature.  
To monitor the kinetics of DNA binding by BsoBI, the protein was labeled with Alexa488 
fluorophore and DNA was labeled with Alexa594 fluorophore. The protein was diluted to 
100 nM concentration in buffer containing CaCl2 (chapter 2.1.4.), to obtain 50 nM 
concentration in the mixture. DNA concentration (diluted in the same buffer) was varied from 
25 nM to 400 nM (in the mixture). The change in fluorescence signal was monitored using 
donor emission filter, since the acceptor labeled component was varied. The signal was 
collected for 100 s, in three time intervals: 0-5 s every 10 ms, 5-50 s every 50 ms, 50-100 ms 
every 100 ms. Monitoring of DNA binding and cleavage was done in buffer containing MgCl2 
(chapter 2.1.4.), with the same protein and DNA concentrations, and measurement setup.  
To monitor conformational changes in protein after DNA binding, protein labeled with both 
donor and acceptor fluorophore was mixed with unlabeled DNA.  
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The influence of different metal ions on the conformation of the protein was monitored by 
mixing double labeled protein with buffer containing excess of the metal ion of interest.  
 
2.2.6.5. Multiparameter single-molecule fluorescence spectroscopy 
 
The results obtained from ensemble steady-state and stopped-flow measurements represent 
the average of events happening in the sample of interest. In order to acquire information 
about subpopulations present in the sample, a series of single-molecule experiments was 
performed. The experimental setup allowed monitoring different fluorescence parameters 
(Figure 2.10) of labeled protein molecules in solution. 
 
 
Figure 2.10 Multiple dimensions of fluorescence monitored. A – Excitation spectrum, B – 
Fluorescence spectrum, C – Fundamental anisotropy, D – Fluorescence lifetime, E – Distance 
between fluorophores, F – Fluorescence quantum yield, G – Time, H – Fluorescence intensity 
(adapted from Widengren et al. [70]) 
 
Single-molecule experiments were carried out on a confocal epi-illuminated setup. Labeled 
protein was diluted in 2 steps, in the measurement buffer, to a concentration of 40-80 pM 
(depending on the degree of labeling). The final dilution was done in a 50 μl droplet used for 
the experiment. To prevent protein adsorption, the glass cover slide was coated with 5 mg/ml 
κ-casein. A droplet of 50 μl of κ-casein was applied to the cover slide and left for 10 minutes. 
Then the droplet was removed, and the spot was carefully washed with water to remove 
excess of κ-casein, and leave only a thin layer at the surface.  
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The excitation was done at 497 nm using an Argon-ion laser (Sabre, Coherent, Palo Alto, CA, 
USA; APE, Berlin, Germany), focused into the solution. Labeled molecules freely diffusing 
in the solution create a burst of fluorescence photons while they travel through the detection 
volume (in the range of femtoliter, restricted by a pinhole of 100 μm in diameter, and the 
beam waist ω0 of 0.56 μm). The objective was a 60 x water immersion lens (Olympus, 
UPlanApo, 60 x, 1.2 N.A). The excitation pulses had a width of 190 ps and a repetition rate of 
73 MHz. The dual-band dichroic mirror separates the incoming excitation wavelength 
fluorescence signal (488/636PC, AHF Analysentechnik, Tübingen, Germany). The 
fluorescence signal is divided into its parallel and perpendicular components with respect to 
the linear polarised excitation beam by a polarising beam splitter cube (Olympus, UPlanApo, 
60 x, 1.2 N.A), and then divided into red and green fluorescence components by further 
dichroic mirrors (DB: 595 DCRX, AHF), resulting in 4 signal paths: green parallel and green 
perpendicular, red parallel and red perpendicular (Figure 2.11).  
 
 
Figure 2.11 The setup for multiparameter fluorescence detection. 
 
Band pass filters (HQ 533/46 and HQ 720/150, for donor and acceptor fluorophore, 
respectively) are finally used to separate the signal in spectral regions from background. Four 
avalanche photodiodes (SPCM-AQR-14, Laser Components, Germany) are used to monitor 
the photons. The PC-BIFL-card (SPC 132, Becker & Hickl GmbH Berlin, Germany) registers 
for each event the arrival time after the laser pulse, the interphoton time and the detector 
channel in which the photon arrives corresponding to spectral range and polarisation. 
Fluorescence bursts created by freely diffusing molecules are distinguished from the 
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background of 1-2 kHz by applying certain selection criteria (~50 μs interphoton time, 
minimum burst size 100 photons). Also, bursts which have acceptor bleaching were removed 
from the analysis by the criterion of the difference in macroscopic times, -0.5 s < TG-TR < 
0.5 s, where TG and TR represent the average macroscopic time in which all photons are 
detected during one burst in the green and red channels, respectively. Without photobleaching 
TG and TR would be similar, and thus TG-TR ≈ 0. Another selection criterion included 
choosing the bursts in the red channel that had more than 20 photons. This allowed for the 
exclusion of the red bursts not originating from FRET, but from crosstalk of green donor 
signal to red acceptor detection channel. In this way significant amount of the donor only 
species was also removed from the analysis.  
First, double labeled protein in different buffers (chapter 2.1.4.) was measured, typically       
1-1,5 h, i.e. until enough photons were collected to ensure good statistical result processing. 
Then, a new droplet with protein was prepared, and excess of specific or unspecific DNA 
(500 nM) was added, and the measurement was repeated.  
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3. Results 
 
The dynamics of conformational changes in the restriction enzyme BsoBI was analyzed using 
different fluorescence techniques. For this purpose, the enzyme had to be labeled with donor 
and/or acceptor fluorophore, at defined positions. The modifications were done using 
fluorophores with the maleimide functional group, and different single-cysteine BsoBI 
variants.  
 
3.1. Determination of binding and cleavage activity of different single-cysteine 
BsoBI variants 
 
In order to specifically label BsoBI with different fluorophores, cysteine residues had to be 
introduced at certain positions of the protein. This was done by removing three naturally 
occurring cysteines from BsoBI, to produce a cysteine-free variant, and subsequently 
introducing single cysteines into specific positions. Using the plasmid containing the gene for 
cysteine-free BsoBI variant, and site-directed mutagenesis (as explained in Chapter 2.2.3.1), 
several single-cysteine BsoBI variants were produced, e.g. E100C, A153C, E290C. The 
presence of the newly introduced cysteines was determined by DNA sequencing. These new 
variants should not have impaired binding and cleavage activity compared to the wild type 
variant. The cleavage tests were done using a plasmid containing one BsoBI recognition site 
(CTCGAG), as described in chapter 2.2.3.6.2. Figure 3.1 shows cleavage assays for BsoBI 
wild type (wt) and the BsoBI A153C variant as one example of single-cysteine variants.  
 
 
Figure 3.1 Activity test of the BsoBI wild type (wt) and the A153C variant. Cleavage of the 
pDGS plasmid, with one BsoBI recognition site, results in appearance of linear DNA in the 
electropherogram. M: GeneRuler™ 1kb DNA ladder (Fermentas); oc: open circle; lin: linear 
plasmid DNA; sc: supercoiled plasmid DNA 
 
It can be seen that cleavage activities of both the wild type enzyme and the single-cysteine 
variant are the same (partial cleavage at 0.195 nM BsoBI, full cleavage at 0.39 nM BsoBI). 
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All single-cysteine variants used in this study were checked for cleavage activity, and neither 
of them showed any cleavage deficiency.  
Based on available literature data [36], certain mutations were introduced into already existing 
single-cysteine variants in order to create binding efficient but cleavage inactive variants. The 
residues chosen were D212, which was exchanged to alanine or asparagine (creating D212A 
and D212N variants, respectively), and H253, which was exchanged to glutamine (creating 
H253Q variant). The amino acids were exchanged in genes coding for BsoBI A153C and 
E100C. First, the binding activity of newly created double variants was checked and 
compared with the binding activity of the wild-type protein and the single-cysteine variant 
from which the double mutant originated (Figure 3.2).  
 
 
Figure 3.2 Binding activity of different BsoBI variants as determined by EMSA. The 
substrate used in the experiments was a 237 bp long PCR product. The binding reaction was 
done in the presence of Poly(dI-dC)·Poly(dI-dC) (GE Healthcare), as polynucleotide that blocks 
unspecific binding. BsoBI concentrations used were: 8 nM, 12 nM, 20 nM,31 nM, 50 nM, 
79 nM, 125 nM, 197 nM, 312 nM, 494 nM. Ø – control reaction without BsoBI.  
 
The binding activity was determined using 1 nM 237 bp long PCR product (with one BsoBI 
recognition site – CTCGAG), and different concentrations of BsoBI (ranging from 8 nM to 
490 nM), as explained in chapter 2.2.3.6.1. The reaction was done in the presence of CaCl2, 
which supports specific DNA binding, but not cleavage. Excess of Poly(dI-dC)·Poly(dI-dC) 
was also added to the reaction, in order to prevent unspecific binding. The introduction of 
cysteine instead of alanine at the position 153 did not cause a significant change in the 
binding efficiency compared to the wild type protein. Also, the exchange of residue D212 in 
the active site to asparagine did not significantly impair the binding activity (estimated KD 
value for wild type was 40 nM, for A153C 65 nM and for A153C/D212N 57 nM). However, 
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the exchange of residue H253 to glutamine caused loss in binding activity. This mutation was 
shown to impair the binding activity also when it was introduced into the variant E100C.  
In addition to checking the binding activity, the newly created double mutants were also 
checked for their cleavage activity (Figure 3.3). Variant A153C/H253Q showed no binding 
activity, and it was thus expected to see no cleavage activity either.  
 
 
Figure 3.3 Activity test of BsoBI A153C/H253Q and A153C/D212N variants. Cleavage of 
the pDGS plasmid, with one BsoBI recognition site, results in appearance of linear DNA in the 
electropherogram. M: GeneRuler™ 1kb DNA ladder (Fermentas); oc: open circle; lin: linear 
plasmid DNA; sc: supercoiled plasmid DNA 
 
As expected, the variant A153C/H253Q did not show cleavage activity. Although the variant 
A153C/D212N showed binding activity, it did not show any cleavage activity. The mutation 
of aspartic acid at the position 212 into asparagine caused loss of cleavage activity, but not in 
binding activity, also when introduced into the BsoBI variant E100C. Mutation of the 
histidine residue at position 253 caused loss of both binding and cleavage activities, 
regardless of into which single-cysteine variant it was introduced.  
 
3.2. Michaelis-Menten kinetics 
 
BsoBI is a thermostable restriction enzyme, purified from the thermophilic gram-positive 
bacterium Bacillus stearothermophilus, with an optimal catalytic activity at 65 °C. However, 
all pre-steady state ensemble experiments, as well as single-molecule experiments were 
carried out at room temperature. Thus, the kinetics of DNA cleavage was analyzed at three 
different temperatures, room temperature (25 °C), 37 °C and 65 °C, in order to compare the 
cleavage rates.  
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Figure 3.4 Michaelis-Menten analysis of DNA cleavage by BsoBI at different 
temperatures. The initial rate constants were plotted as a function of substrate concentration, 
and the hyperbolic function was used to fit the data obtained.  
 
The collected data was analyzed using the GraphPad Prism software, in order to fit the 
experimental points to the hyperbolical function that describes the Michaelis-Menten kinetics. 
Figure 3.4 shows the dependence of initial rate constants on the substrate concentration used, 
at three different temperatures.  
Using the Michaelis-Menten equation (Chapter 2.2.4), the values for Vmax and KM could be 
determined. The value for kcat was calculated by dividing Vmax by the total enzyme 
concentration. Table 7 represents the Michaelis-Menten parameters for DNA cleavage by 
BsoBI at three different temperatures.  
 
Table 7 
  25 °C 37 °C 65 °C 
Vmax [pM/s] 60.9 3.4 1.1 
KM [nM] 20.3 3.0 0.5 
kcat [s-1] 0.6 0.3 1.1 
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It can be seen that an increase in the temperature causes a decrease of the KM value, 
suggesting that BsoBI has a higher affinity for the substrate at higher temperatures. However, 
the values of the cleavage rates (kcat) were not significantly affected by the change in 
temperatures. Although the optimal conditions for determining the Michaelis-Menten 
parameters were not achieved (Michaelis-Menten plots need to reach a plateau), it is clear that 
the temperature changes influence the KM of BsoBI.  
 
3.3. Site-specific labeling of BsoBI 
 
In order to study conformational changes in BsoBI as well as the interaction between BsoBI 
and DNA using FRET, single-cysteine variants of BsoBI had to be labeled with one or two 
fluorophores, depending on the type of experiment. The labeling positions were chosen so that 
they do not interfere with the catalytic center of BsoBI, that they are surface exposed and that 
the distance between them is optimal for FRET studies. Three single-cysteine variants used in 
different fluorescence experiments are represented in Figure 3.5.  
 
                  
 
Figure 3.5 Position of the three single-cysteine substitutions chosen, represented in the co-
crystal structure of the wt enzyme. a) BsoBI A153C, b) BsoBI E290C, c) BsoBI E100C; 
Green and pink spheres represent residues that were mutated into cysteines and labeled with 
donor and acceptor fluorophores, respectively.  
 
 
a b 
c 
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3.3.1. Random double labeling of BsoBI used in ensemble experiments 
 
Labeling of BsoBI used in pre-steady state and steady-state experiments was done randomly 
using a mixture of donor and acceptor fluorophores. The acceptor fluorophore was added in 
excess, to minimize the amount of protein molecules labeled only with donor fluorophore. 
The protein stock solutions were kept in a buffer containing 2-mercaptoethanol, which had to 
be removed prior to labeling reaction. This was done using a HiTrapTM Desalting column (GE 
Healthcare) as described in chapter 2.2.5.1.  
Conformational changes following substrate binding and/or cleavage was monitored by 
mixing double labeled BsoBI with unlabeled DNA. For this purpose, mixture of donor and 
acceptor fluorophore, in a ratio of 1:10 respectively, was added to the protein and allowed to 
react for 30 min at room temperature. Unreacted fluorophore was removed using a HiTrapTM 
Desalting column.  
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Figure 3.6 Chromatography steps during random BsoBI labeling. a) Chromatogram of 
removal of 2-ME from protein stock solution, b) Chromatogram of removal of excess of 
Alexa488 and Alexa594, c) Chromatogram of removal of excess of Alexa488. The green box 
represents the portion of eluted protein used for further labeling. Red boxes represent the 
portions of eluted protein used in experiments 
 
a 
b c 
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The kinetics of binding and/or cleavage of substrate was monitored using single labeled 
BsoBI and single labeled DNA. In this case, BsoBI was labeled with donor fluorophore, and 
excess of unreacted fluorophore was removed as previously described, while DNA was 
labeled with acceptor fluorophore. Figure 3.6 shows chromatograms of 2-ME and free 
fluorophore removal.  
The chromatogram in Figure 3.6.a shows co-elution of species that absorb at 280 nm 
(maximal absorption for protein) and 250 nm (maximal absorption for 2-ME). However, 
protein also absorbs at 250 nm, so this 250 nm absorption does not represent 2-ME still bound 
to BsoBI.  
Figure 3.6.b shows co-elution of species that absorb at 280 nm (maximal absorption for 
protein), 488 nm (maximal absorption for Alexa488) and 594 nm (maximal absorption for 
Alexa594). It is clearly visible that the protein is labeled with both donor and acceptor 
fluorophore, and that the majority of free fluorophore can be removed using this 
chromatography step. The amount of free flurophores still present after this purification is 
removed after o/n dialysis against storage buffer.  
Figure 3.6.c shows the removal of free Alexa488 fluorophore after BsoBI labeling. Again, it 
is clear that protein and Alexa488 co-elute, suggesting that the protein is labeled, and that 
most of the unreacted fluorophore can be removed.  
Red boxes in Figure 3.6.b and c show the elution fractions that were collected and dialysed 
o/n against storage buffer, and used in further experiments.  
The purity of the labeled protein was confirmed using SDS-PAGE (chapter 2.2.2.1.1.). Figure 
3.7 shows one example of the double labeled BsoBI A153C variant before and after removing 
the unreacted fluorophore. The gel was photographed under UV light, prior to staining, in 
order to observe the fluorescence of labeled protein and unreacted fluorophore, and then 
washed and stained as described in chapter 2.2.2.1.1.  
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Figure 3.7 SDS-PAGE of double labeled BsoBI A153C variant. 1) Double labeled BsoBI 
A153C before removing the free dye, 2) Double labeled BsoBI A153C after removing the free 
dye, 3) Unlabeled BsoBI A153C stained with Coomassie Brilliant Blue, 4) Double labeled 
BsoBI A153C before removing the free dye stained with Coomassie Brilliant Blue, 5) Double 
labeled BsoBI A153C after removing the free dye stained with Coomassie Brilliant Blue, M – 
PageRulerTM Protein Ladder (Fermentas) 
 
Unreacted fluorophore (free dye) can be seen only in lane 1, in the sample of double labeled 
BsoBI before purification. BsoBI appears as a single band, which represents one subunit with 
the size of approximately 38 kDa.  
Table 8 shows one example of labeling efficiencies and concentrations of BsoBI and 
fluorophores after this labeling protocol. The degree of labeling was calculated as described in 
chapter 2.2.5.3, using the correction factor for fluorophore absorption at 280 nm, and taking 
into account that there are two positions for labeling per homodimeric A153C.  
 
Table 8 
 
  Concentration DOL   
A153C A488/A594 A488 138 μM 20 % 81 % 
235 μM A594 285 μM 61 % 
A153C A488 
A488 155 μM 61 % 
  
128 μM   
DOL: degree of labeling; A488: Alexa488; A594: Alexa594 
 
The introduction of the labels should not influence binding or cleavage of specific DNA, and 
therefore all labeled proteins were analyzed for cleavage activity. The procedure for 
determination of cleavage activity is explained in chapter 2.2.3.6.2. Figure 3.8 shows the 
result of the cleavage assays for BsoBI A153C labeled with Alexa488 and Alexa647, 
unlabeled BsoBI A153C and BsoBI wild type (wt).  
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Figure 3.8 Activity test of double labeled BsoBI A153C, unlabeled BsoBI A153C and 
BsoBI wt. Cleavage of the pDGS plasmid, with one BsoBI recognition site, results in 
appearance of linear DNA in the electropherogram. M: GeneRuler™ 1kb DNA ladder 
(Fermentas); oc: open circle; lin: linear plasmid DNA; sc: supercoiled plasmid DNA 
 
The plasmid used in the activity test has one BsoBI recognition site, and the cleavage activity 
is reflected in appearance of linear DNA, and disappearance of supercoiled plasmid. The 
activity assay shows that neither the introduction of cysteines nor fluorophores influences the 
cleavage activity of BsoBI (partial cleavage at 10 pM BsoBI, full cleavage at 100 pM BsoBI).  
 
3.3.2. Double labeling of BsoBI used in single-molecule experiments 
 
BsoBI is a homodimer, so introduction of cysteine in one of the subunits leads to introduction 
of cysteine at the same position in the second subunit. To improve the labeling procedure, 
which would lead to BsoBI homodimer labeled with donor fluorophore on one subunit, and 
acceptor fluorophore on the other subunit, a two-step labeling procedure was used. 
Chromatography steps during this process are presented in Figure 3.9.  
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Figure 3.9 Chromatography steps during the two-step double labeling of BsoBI A153C. a) 
Chromatogram of removal of 2-ME from protein stock solution, b) Chromatogram of removal 
of excess of Alexa488, c) Chromatogram of separation of differently labeled proteins, d) 
Chromatogram of removal of excess of Alexa594. The green box represents the portion of eluted 
protein used for further labeling. Red boxes represent the portions of eluted protein used in 
further experiments. The gray box represents the portion of eluted protein used for labeling with 
Alexa594. 
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As described previously, 2-ME was removed from the protein stock solution, and the eluted 
protein was labeled with donor fluorophore added in molar excess of 1-fold over BsoBI dimer 
(in stoichiometric amounts to the cysteines). The excess of unreacted fluorophore was 
removed as previously described.  
Figure 3.9.c shows the chromatogram of separating differently labeled protein molecules, 
carried out using a ResourceQTM column. The first peak (around 10 ml elution volume) 
represents BsoBI molecules that are not labeled with Alexa488 fluorophore. The second peak 
(between 12 and 15 ml elution volume) shows the co-elution of species that absorbs at 
280 nm and 488 nm, namely protein and Alexa488 fluorophore. This peak represents BsoBI 
molecules labeled with one and two fluorophores. However, the separation of the two 
differently labeled populations is not complete, and the gray box represents the portion of 
eluted protein that was used for labeling with acceptor fluorophore. Most of the protein used 
has none or one fluorophore attached to cysteine, but some of the molecules also have two 
fluorophores, since the separation was not complete. This can be seen in single-molecule 
experiments, where the population labeled only with donor appears in the double labeled 
sample.  
Subsequently, the portion of eluted protein marked with a gray box in Figure 3.9.c was 
labeled with a 10-fold molar excess of acceptor fluorophore, either Alexa594 or Alexa647. 
Also, 200 μl of the chosen eluted portion was kept labeled only with donor fluorophore, and 
dialysed against storage buffer, to serve as single (donor) labeled sample. Figure 3.9.d shows 
the chromatogram of removing the excess of unreacted Alexa594 fluorophore via gel 
filtration. 
In Table 9 two examples of labeling efficiencies for double and single labeled BsoBI A153C 
are shown, obtained after the purification described, using the correction factor for 
fluorophore absorption at 280 nm (Chapter 2.2.5.3), and taking into account that there are two 
positions for labeling per homodimeric A153C.  
 
Table 9 
    Concentration DOL   
A153C A488/A594 A488 4.2 μM 9 % 90.7 % 
14.2 μM A594 23.2 μM 81.7 % 
A153C A488 
A488 8.3 μM 12.4 % 
  
33.4 μM   
DOL: degree of labeling; A488: Alexa488; A594: Alexa594 
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3.4. DNA binding induces conformational changes in the catalytic domain of 
BsoBI 
 
Conformational changes induced by substrate binding and cleavage were monitored in steady-
state ensemble experiments by mixing different double labeled BsoBI variants with unlabeled 
DNA. The variant A153C has cysteines introduced in the catalytic domain, and variant E100C 
has cysteines introduced in the helical domain. The effect of DNA binding was investigated in 
the presence of different divalent metal ions, namely Ca2+ and Mg2+. Mg2+ ion is the natural 
metal ion cofactor which supports specific binding and cleavage of the DNA substrate. In 
contrast, Ca2+ ions enable only specific binding of the substrate, but not cleavage. 
Conformational changes observed in the presence of Ca2+ represent the changes the protein 
undergoes while binding to the specific DNA site. Conformational changes observed in the 
presence of Mg2+ represent the changes the protein undergoes while binding and cleaving the 
specific DNA substrate.  
First, double labeled BsoBI variant A153C was diluted in buffer containing CaCl2 (chapter 
2.1.4), to give a concentration of 50 nM, and the fluorescence spectrum, after excitation at 
470 nm, was recorded (Figure 3.10.a). Then an excess of the specific 39 bp long 
oligonucleotide was added to the cuvette, and the measurement was repeated. The same 
experiment was done in the presence of MgCl2 (Figure 3.10.b).  
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Figure 3.10 Influence of DNA binding on the conformation of the catalytic domain of 
BsoBI. a) Conformational changes upon specific DNA binding (in the presence of CaCl2); black 
line: protein alone, red line: addition of the 39 bp long oligonucleotide, b) conformational 
changes upon specific DNA binding and cleavage (in the presence of MgCl2); black line: 
protein alone, red line: addition of the 39 bp long oligonucleotide. 
 
It can be seen that the addition of specific DNA to the double labeled A153C variant, in the 
presence of CaCl2, causes a decrease of the FRET signal and increase of the donor signal, 
a b 
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which reflects the movement of two fluorophores away from each other. In contrast, the 
addition of specific DNA to the double labeled A153C variant, in the presence of MgCl2, does 
not induce a FRET change. Due to the fact that BsoBI is able to cleave DNA in the presence 
of MgCl2, this ensemble experiment shows the average signal originating from molecules 
bound to DNA and molecules that released the product of cleavage, and thus it cannot resolve 
different species. Also, in the time between mixing the enzyme and DNA, and recording the 
spectrum (1-2 min), most of the enzyme already had cleaved the substrate, and only enzyme 
bound to the product and/or free enzyme can be detected.  
In the control experiment, the double labeled BsoBI variant E100C was used, and mixed with 
DNA in the presence of CaCl2 (Figure 3.11.a) or MgCl2 (Figure 3.11.b).  
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Figure 3.11 Influence of DNA binding on the conformation of the helical domain of BsoBI. 
a) Conformational changes upon specific DNA binding (in the presence of CaCl2); black line: 
protein alone, red line: addition of the 39 bp long oligonucleotide, b) conformational changes 
upon specific DNA binding and cleavage (in the presence of MgCl2); black line: protein alone, 
red line: addition of the 39 bp long oligonucleotide. 
 
The addition of unlabeled specific DNA substrate to the double labeled BsoBI variant E100C, 
either in the presence of CaCl2 or MgCl2, did not induce a significant FRET change, implying 
that there is no major movement of the fluorophores placed in the helical domain of BsoBI 
upon DNA binding and cleavage.  
Based on the spectra obtained in previously described experiments, and using the equations 
described in chapter 2.2.6.2. the efficiency of FRET signal and the distance between two 
fluorophores for different experiments was calculated. The average of three measurements for 
different BsoBI variants, as well as different metal ions used, is presented in Figure 3.12.  
 
a b 
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Figure 3.12 Distances between two fluorophores for different BsoBI variants and different 
buffer conditions as estimated using FRET data. Gray bars: double labeled BsoBI without 
DNA; Red bars: double labeled BsoBI with specific DNA 
 
The distance between the two symmetry related residues A153, measured on the basis of the 
co-crystal structure, is 77 Å, which is in good agreement with the distance obtained in FRET 
measurements done in the presence of CaCl2 and specific DNA. Distances calculated for 
BsoBI alone could not be compared with those from crystal structure, since there is no crystal 
structure without DNA available.  
The distance between the two E100 residues based on the co-crystal structure is 46 Å, while 
distances calculated from FRET measurements are in the range between 60 Å and 65 Å. 
However, the position of these cysteines, which suggests that the fluorophores are positioned 
away from the enzyme, (Figure 3.5.c) and the fact that fluorophores are linked to the protein 
via a C5 linker, may explain the differences between calculated and theoretical values.  
 
3.5. Ca2+ and Mg2+ ions have a different influence on the catalytic domain of 
BsoBI 
 
Previously described experiments revealed a different behaviour of free BsoBI A153C in the 
presence of CaCl2 and MgCl2 (Figure 3.12). In order to study in more detail this effect, the 
double labeled BsoBI variant A153C was diluted into three different buffers, and the FRET 
was measured. The buffers contained 5 mM CaCl2 or 5 mM MgCl2 or 0.5 mM EDTA (Figure 
3.13.a). The same experiments were repeated with the double labeled BsoBI variant E100C as 
a control, to study the effect of divalent metal ions on the helical domain (Figure 3.13.b).  
40
45
50
55
60
65
70
75
80
A153C CaCl A153C MgCl E100C CaCl E100C MgCl
D
ist
an
ce
 [Å
]
BsoBI
BsoBI + DNA
2 2 2 2 
 Results | 58  
 
500 550 600 650 700
0
100
200
300
400
500
600
700
800
900
1000
 A153C A488/A594 CaCl2
 A153C A488/A594 MgCl2
 A153C A488/A594 EDTA
 
 
Fl
uo
re
sc
en
ce
 [a
.u
.]
Wavelength [nm]
500 550 600 650 700
0
100
200
300
400
500
600
700
800
900
1000
 
 
Fl
uo
re
sc
en
ce
 [a
.u
.]
Wavelength [nm]
 E100C A488/A594 CaCl2
 E100C A488/A594 MgCl2
 E100C A488/A594 EDTA
 
Figure 3.13 Influence of different divalent metal ions on the structure of BsoBI. a) 
Influence of Ca2+ and Mg2+ on the catalytic domain of BsoBI, b) Influence of Ca2+ and Mg2+ on 
the helical domain of BsoBI; All experiments were done in the absence of DNA. Brown line: 
BsoBI in the presence of CaCl2; Orange line: BsoBI in the presence of MgCl2; Green line: 
BsoBI in the absence of metal ions and in the presence of EDTA. 
 
It could be seen that the addition of CaCl2 induces a conformational change in the catalytic 
domain of BsoBI which brings two fluorophores attached to the cysteines at the position 153 
closer together. In the control experiment, in which double labeled BsoBI variant E100C was 
used, no significant change could be seen after measuring the FRET signal in the presence of 
MgCl2 or EDTA.  
In addition, FRET values were determined for different CaCl2 concentrations in the buffer, 
using the double labeled variant A153C. The results are presented in Figure 3.14 as the 
influence of the CaCl2 concentrations on the FA/FD ratio. This ratio is calculated by dividing 
the maximum fluorescence of the FRET signal (FA) by the maximum fluorescence of the 
donor signal (FD) in the double labeled protein. 
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Figure 3.14 Influence of different CaCl2 concentrations on the conformation of double 
labeled A153C variant. All experiments were done in the absence of DNA 
 
Based on the curve obtained, the estimated value for the binding constant (KD) for Ca2+ ions 
to the protein is 1.1 ± 0.5 mM. 
 
3.6. Pre-steady state experiments reveal different enzyme kinetics in the presence 
of Ca2+ and Mg2+ ions 
 
In order to study the kinetics of conformational changes in BsoBI, a series of pre-steady state 
experiments was done. The experiments were carried out using either double labeled BsoBI 
and unlabeled DNA, or single labeled BsoBI and labeled DNA. All experiments were done at 
room temperature, and using the same buffers used in the steady-state and single-molecule 
measurements. 
 
3.6.1. Kinetics of conformational changes induced by DNA binding to the double labeled 
BsoBI A153C variant 
 
In order to study the kinetics of conformational changes in BsoBI induced by DNA binding, a 
series of stopped-flow experiments was done using double labeled BsoBI and an unlabeled 
specific oligonucleotide (39 bp). Double labeled BsoBI A153C variant was diluted to 100 nM 
in buffer containing CaCl2, to give a final concentration of 50 nM enzyme in the mixing 
chamber. The use of CaCl2 allows only specific binding, but not cleavage of DNA. The 
second syringe contained 800 nM unlabeled DNA, diluted in same buffer, to give a final 
concentration of 400 nM in the mixing chamber. This solution was diluted with buffer, in 
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order to achieve four additional DNA concentrations (200 nM, 100 nM, 75 nM and 50 nM). 
The changes were observed during 100 s, in three time intervals with different number of data 
points collected: 0-5 s each 10 ms (501 data points), 5-50 s each 50 ms (900 data points) and 
50-100 s each 100 ms (500 data points) (Figure 3.15). Bandpass filter D515/30m (LOT Oriel) 
was used in order to monitor changes in the donor signal.  
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Figure 3.15 Kinetics of conformational changes induced by DNA binding. Double labeled 
BsoBI A153C variant was diluted with buffer containing CaCl2, to a final concentration in the 
mixing chamber of 50 nM. Experimental time traces are shown in gray, and fitted curves are 
shown in red. On the left a scheme of the stopped flow reaction is shown.  
 
Binding of DNA to the double labeled BsoBI A153C variant induces an increase in the donor 
signal (and consequently a decrease in the FRET signal), suggesting that the conformational 
change in the catalytic domain of BsoBI moves the two fluorophores further apart. 
Experimental traces were analyzed using the DynaFit (Biokin) program [69], which performs 
a nonlinear least-squares regression of the kinetic data. The program performed a global 
analysis, i.e. fitted all experimental curves simultaneously to the same set of rate constants. 
The curves obtained are shown in red in Figure 3.15. The result of the global analysis is 
presented in the following scheme: 
E1 E2
DNA
E2D
0.03 s-1
0.02 s-1
0.5 µM-1s-1
 
It can be seen that the enzyme exists in at least two different conformations (E1 and E2), one 
of which (E2) is slightly favored (equilibrium constant 1.5), and able to bind DNA. DNA 
BsoBI 
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A594 
CaCl2 
39 bp 
sp. DNA 
CaCl2 
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binding can be therefore described as a two step reaction: a first order conformational change 
followed by a second order association of DNA to the binding competent BsoBI, with a rate 
constant of 0.5 μM-1s-1. The errors for the rate constants obtained were between 1 % and 6 %.  
 
3.6.2. Kinetics of DNA binding to the BsoBI A153C variant using fluorescently labeled 
DNA and labeled protein 
 
The kinetics of DNA binding was monitored in the stopped-flow setup, using donor labeled 
BsoBI and acceptor labeled 39 bp long specific oligonucleotide. Both protein and DNA were 
diluted in buffer containing Ca2+ ions, which enables specific binding but not the cleavage of 
DNA. BsoBI was diluted to 100 nM in one syringe, making the end concentration in the 
mixing chamber 50 nM. The first DNA concentration was 800 nM (400 nM in mixing 
chamber), and this solution was diluted for further experiments to make four additional 
concentrations (200 nM, 100 nM, 75 nM and 50 nM). Since the concentration of acceptor 
labeled DNA was varied during the experiments, the changes in donor signal were monitored 
(Figure 3.16).  
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Figure 3.16 Kinetics of DNA binding in the presence of Ca2+ ions. Single (donor) labeled 
BsoBI was diluted with buffer containing CaCl2, to a final concentration in the mixing chamber 
of 50 nM. Experimental time traces of the donor signal are shown in gray, and fitted curves are 
shown in red. On the left a scheme of the stopped flow reaction is shown. 
 
As the result of the acceptor labeled DNA binding to the donor labeled BsoBI, donor signal 
decreased. The obtained experimental traces were analyzed using the DynaFit (Biokin) 
program, performing a global analysis. The resulted fits are shown in red in Figure 3.16, and 
also presented in the following scheme:  
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As in the experiment with double labeled protein, BsoBI exists in at least two conformations 
before binding the DNA, although the equilibrium constant is slightly different compared to 
the previous experiment, which is not too surprising, since in the two sets of experiments 
differently labeled reaction partners were used. DNA binding is described as a second order 
association, with a rate constant of 0.2 μM-1s-1.  
 
3.6.3. Kinetics of DNA binding and cleavage in the presence of Mg2+ ions 
 
In order to monitor the kinetics of binding and cleavage of specific DNA by BsoBI, donor 
labeled BsoBI and acceptor labeled 39 bp long specific oligonucleotide were mixed in the 
presence of Mg2+ ions, and the donor signal was monitored. After DNA binding, the donor 
signal decreases due to association of the acceptor labeled DNA and thus appearance of 
FRET. After DNA cleavage and product release, the donor signal increases due to 
dissociation of the acceptor labeled product. The concentration of BsoBI in the syringe was 
100 nM, which made the concentration in the mixing chamber 50 nM. The start concentration 
of DNA was 800 nM, making the concentration in the mixing chamber 400 nM. This solution 
was subsequently diluted to give four additional concentrations (200 nM, 100 nM, 75 nM and 
50 nM, in the mixing chamber). The reactions were monitored after mixing 100 μl of each 
species in the mixing chamber. For each concentration 10-20 curves were obtained, and 
averaged using the Biokine 2.07 software (Figure 3.17).  
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Figure 3.17 Kinetics of DNA binding and cleavage in the presence of Mg2+ ions. Single 
(donor) labeled BsoBI was diluted with buffer containing MgCl2, to give a final concentration in 
the mixing chamber of 50 nM. Experimental time traces of the donor signal are shown in gray, 
and fitted curves are shown in red. On the left a scheme of the stopped flow reaction is shown. 
 
The experimental data (gray in Figure 3.17) obtained were analyzed using the DynaFit 
(Biokin) program, performing a global analysis, and presented in red in Figure 3.17 and as a 
scheme below: 
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E2 + P
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As can be seen, BsoBI exists in two conformations before binding the DNA, one of which is 
slightly more favored (E2 in the scheme). DNA binding is described as a second order 
association reaction, with a rate constant of 4.8 μM-1s-1, approximately 20 times higher than in 
the binding experiments using Ca2+ ions.  
 
3.6.4. Influence of Ca2+ and Mg2+ ions on the conformation of the catalytic domain of 
BsoBI 
 
The observed influence of different metal ions on the conformation of the catalytic domain of 
BsoBI was analyzed in the stopped-flow setup, using double labeled BsoBI and buffers with 
different concentrations of Ca2+ or Mg2+ ions.  
First, double labeled BsoBI A153C variant was diluted with a buffer containing 5.5 mM 
CaCl2, and mixed with buffer containing increasing concentrations of MgCl2. The bandpass 
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filter D630/30 (LOT Oriel) was used in order to monitor the changes in acceptor signal 
(Figure 3.18). The changes were monitored for 100 s, in three time intervals, with different 
number of data points collected: 0-5 s each 10 ms (501 data points), 5-50 s each 50 ms (900 
data points) and 50-100 s each 100 ms (500 data points). Double labeled BsoBI was diluted to 
100 nM with a buffer containing 5.5 mM CaCl2. After mixing equal volumes of labeled 
protein and a MgCl2 containing buffer, the final concentrations in mixing chamber were half 
of the starting concentrations (50 nM BsoBI, 2.75 mM CaCl2, 2.75-27.5 mM MgCl2).  
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Figure 3.18 Kinetics of the conformational changes of the catalytic domain of BsoBI 
induced by replacing Ca2+ ions by Mg2+ ions. The double labeled BsoBI A153C variant (50 
nM) was diluted with buffer containing CaCl2, and mixed with buffer containing different 
concentrations of MgCl2. The acceptor signal was monitored. On the left a scheme of the 
stopped flow reaction is shown. 
 
It can be seen that the FRET signal decreases when Mg2+ ions replace Ca2+ ions in the double 
labeled BsoBI A153C variant, suggesting that the conformational changes in the catalytic 
domain of BsoBI move the two fluorophores further apart. The traces obtained were fitted 
with first order exponential curves, and one example of the fitted curve is presented in Figure 
3.19.  
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Figure 3.19 Influence of the highest MgCl2 concentration on the conformation of BsoBI. 
The time trace of the acceptor signal is fitted with a first order exponential curve, resulting in a 
rate constant of 0.085 ± 0.002 s-1.  
 
All traces were fitted in the same way, and the resulting rate constants were plotted as a 
function of MgCl2 concentrations (Figure 3.20).  
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Figure 3.20 Observed apparent rate constants for the conformational changes as a 
function of MgCl2 concentrations.  
 
As can be seen in Figure 3.20, the rate of the conformational changes in the catalytic domain 
of BsoBI are dependent on the concentration of Mg2+ ions used, namely, with the increase of 
MgCl2 concentration, the apparent rate constant is increasing.  
In order to study the influence of Ca2+ ions replacing Mg2+ ions on the conformation of the 
catalytic domain of BsoBI, double labeled BsoBI A153C variant was diluted with buffer 
containing 5.5 mM MgCl2 and mixed with increasing concentrations of CaCl2. The 
concentrations of double labeled protein, as well as metal ions used, were the same as the 
CCa = 2.75 mM 
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ones used in the previously described experiments. As in the previous case, the changes in 
acceptor signal were monitored (Figure 3.21).  
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Figure 3.21 Kinetics of conformational changes of catalytic domain of BsoBI induced by 
replacing Mg2+ ions by Ca2+ ions. The double labeled BsoBI A153C variant (50 nM) was 
diluted with buffer containing MgCl2, and mixed with a buffer containing different 
concentrations of CaCl2. The acceptor signal was monitored. On the left a scheme of the 
stopped flow reaction is shown.  
 
The Figure 3.21 shows the increase in FRET signal after replacing Mg2+ ions with Ca2+ ions, 
suggesting that the conformational change in the catalytic domain of BsoBI moves the two 
fluorophores closer together. As previously described, all traces were fitted with first order 
exponential curves, and examples of one CaCl2 concentration and the dependence of the 
apparent rate constant on the CaCl2 concentration is shown in Figure 3.22 and Figure 3.23, 
respectively.  
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Figure 3.22 Influence of the highest CaCl2 concentration on the rate of the conformational 
change of BsoBI. The time trace of the acceptor signal is fitted with a first order exponential 
curve, resulting in a rate constant of 0.0267 ± 0.0006 s-1. 
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Figure 3.23 Observed apparent rate constants for the conformational change as a function 
of CaCl2 concentrations.  
 
In contrast to the results of the previous experiments, the rate constant is decreasing with the 
increase of CaCl2 added, although the change is not as pronounced as in the case of the MgCl2 
addition (Figure 3.24).  
CMg = 2.75 mM 
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Figure 3.24 Comparison of the influence of the metal ion used on the apparent rate 
constant of the conformational change of the BsoBI catalytic domain. 
 
If the exchange of Ca2+ is faster than the one of Mg2+, the signal monitored is the exchange of 
Mg2+, since this is the rate limiting step, and the description of the exchange rates can be 
presented by the following equation (detailed calculations are presented in Supplementary 
information) describing the relationship between the apparent rate constant k in terms of the 
association and dissociation rate constants for Mg2+ and Ca2+ and their concentrations:  
 
Where k1 and k-1 are the association and dissociation rate constants of Mg2+, respectively, 
while k2 and k-2 are the association and dissociation rate constants of Ca2+, respectively. It is 
clear that the increase of the CaCl2 concentration will cause the decrease of the exchange 
rates. Vice versa, the increase of the MgCl2 concentration will cause the increase of the 
exchange rates.  
 
The influence of different metal ions was also studied by mixing the double labeled BsoBI 
A153C variant diluted in a buffer containing 0.5 mM EDTA with buffers containing either 
5.5 mM CaCl2 or 5.5 mM MgCl2 (Figure 3.25). The final concentration of BsoBI in the 
mixing chamber was 50 nM, while the concentrations of all divalent metal ions and EDTA 
were half of the starting values. The change in acceptor signal was monitored for 100 s, in 
time intervals described in previous experiments.  
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Figure 3.25 Kinetics of the conformational changes of the catalytic domain of BsoBI 
induced by replacing EDTA by Ca2+ or Mg2+ ions. The double labeled BsoBI A153C variant 
(50 nM) was diluted with buffer containing 0.5 mM EDTA, and mixed with a buffer containing 
5.5 mM CaCl2 or MgCl2. The first order exponential fit of CaCl2 addition resulted in rate 
constant of 0.038 ± 0.003 s-1. The acceptor signal was monitored. On the left a scheme of the 
stopped flow reaction is shown. 
 
The replacement of EDTA by Ca2+ ions induces an increase in the FRET signal, suggesting a 
conformational change in the catalytic domain of BsoBI that moves the two fluorophores 
closer together. In contrast, the addition of MgCl2 containing buffer did not induce any 
change in acceptor (FRET) signal, suggesting no conformational change in the catalytic 
domain of BsoBI.  
 
3.6.5. Influence of Ca2+ and Mg2+ ions on the catalytic activity of BsoBI 
 
In order to further study the influence of different divalent metal ions on BsoBI, a series of 
pre-steady state experiments was done using different mixtures of Ca2+ and Mg2+ ions: 
 
1. Donor labeled BsoBI and acceptor labeled specific DNA pre-mixed in the presence of 
EDTA + 5.5 mM CaCl2 versus 5.5 mM MgCl2 or 5.5 mM CaCl2 versus 55 mM MgCl2 
 
First, the donor labeled BsoBI A153C variant and the acceptor labeled 39 bp long specific 
oligonucleotide were pre-mixed in the presence of EDTA. The concentration of BsoBI was 
100 nM (giving a 50 nM final concentration in the mixing chamber), while the concentration 
of DNA was 150 nM (75 nM in the mixing chamber). This complex was mixed with buffers 
containing 5.5 mM CaCl2 and either 5.5 mM or 55 mM MgCl2 (Figure 3.26). The donor 
signal was monitored for 100 s in time intervals described in previous experiments. The 
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cleavage and release of acceptor labeled DNA causes an increase in the donor signal, as the 
result of the disappearance of FRET.  
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Figure 3.26 Kinetics of DNA cleavage in the presence of Ca2+ and Mg2+ ions. Donor labeled 
BsoBI and acceptor labeled DNA were pre-mixed in buffer containing EDTA, and then mixed 
with buffers containing 5.5 mM CaCl2 and either 5.5 mM MgCl2 (black curve) or 55 mM MgCl2 
(red curve). On the left a scheme of the stopped flow reaction is shown. 
 
From Figure 3.26 it can be seen that the mixture of equal concentrations of CaCl2 and MgCl2 
causes residual substrate binding (decrease of the signal at the beginning of the black curve) 
and then very slow cleavage of specific DNA (increase of the signal at the end of the black 
curve). In contrast, the 10-fold excess of MgCl2 over CaCl2 causes fast cleavage of specific 
DNA pre-bound to BsoBI in the presence of EDTA.  
 
2. Donor labeled BsoBI and acceptor labeled specific DNA pre-mixed in the presence of 
EDTA + 5.5 mM MgCl2 or 55 mM MgCl2 
 
Next, the donor labeled BsoBI A153C variant was pre-mixed with the acceptor labeled 39 bp 
long specific oligonucleotide in the presence of EDTA, in the same concentrations as in the 
previous experiment. This complex was mixed with buffer containing different concentrations 
of MgCl2 (Figure 3.27). Donor signal was monitored for 50 s, in the time intervals described 
previously. Again, the cleavage and release of donor labeled DNA causes an increase of 
donor signal.  
BsoBI 
A488 
DNA A594 
EDTA 
CaCl2 + 
MgCl2 
 Results | 71  
 
0 10 20 30 40 50
0.00
0.04
0.08
0.12
 
 
5.5 mM MgCl2
Si
gn
al
 [V
]
Time [s]
55 mM MgCl2
 
Figure 3.27 Kinetics of DNA cleavage in the presence of different MgCl2 concentrations. 
Donor labeled BsoBI and acceptor labeled DNA were pre-bound in the presence of 0.5 mM 
EDTA and mixed with buffers containing either 5.5 mM MgCl2 (black curve) or 55 mM MgCl2 
(red curve). On the left a scheme of the stopped flow reaction is shown. 
 
After mixing BsoBI-DNA complex pre-bound in 0.5 mM EDTA with 5.5 mM MgCl2, there is 
a lag phase in the signal, and possibly certain residual substrate binding (small decrease of the 
signal in black curve in Figure 3.27), after which the cleavage and product release is 
happening. In contrast, when 55 mM of MgCl2 was used, the cleavage and release of the 
product is much faster, and the first part of the signal is lost in the dead-time of the stopped-
flow machine (red curve in Figure 3.27).  
 
3. Donor labeled BsoBI and acceptor labeled specific DNA pre-mixed in the presence of 
5.5 mM CaCl2 + 5.5 mM MgCl2 or 55 mM MgCl2 
 
Finally, the donor labeled BsoBI A153C variant was pre-mixed with the acceptor labeled 
39 bp long specific oligonucleotide, in the presence of 5.5 mM CaCl2, using the same 
concentrations as in the previous experiments. This complex was mixed with buffers 
containing either 5.5 mM MgCl2 or 55 mM MgCl2 (Figure 3.28). The donor signal was 
monitored for 100 s, in the time intervals previously described. The increase of this signal 
indicated the cleavage and release of acceptor labeled DNA.  
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Figure 3.28 Kinetics of DNA cleavage in the presence of different MgCl2 concentrations. 
Donor labeled BsoBI and acceptor labeled DNA were pre-bound in the presence of 5.5 mM 
CaCl2 and mixed with buffers containing either 5.5 mM MgCl2 (black curve) or 55 mM MgCl2 
(red curve). On the left a scheme of the stopped flow reaction is shown. 
 
Equimolar concentrations of CaCl2 and MgCl2 cause very slow cleavage of DNA (black curve 
in Figure 3.28). After addition of a 10-fold excess of MgCl2 over CaCl2, there is fast cleavage 
of DNA pre-bound to BsoBI in the presence of 5.5 mM CaCl2 (red curve in Figure 3.28).  
 
3.7. Single-molecule experiments reveal the existence of two conformations of free 
BsoBI 
 
In order to investigate in more detail the conformational changes during DNA binding by 
BsoBI, a series of single-molecule experiments were done using smMFD (single-molecule 
multiparameter fluorescence detection). These experiments allowed for separation of 
subpopulations present in the sample, which are hidden during the ensemble experiments. The 
results obtained are presented in 2D frequency histograms of SG/SR vs. τD(A). SG/SR represents 
the ratio between green and red fluorescence, corrected for background, detection efficiencies 
and crosstalk, and τD(A) represents the donor lifetime in the presence of acceptor. Figure 3.29 
shows a theoretical example of this kind of data representation.  
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Figure 3.29 2D frequency histogram of SG/SR vs. τD(A). 1 – Low FRET / donor only 
population; 2 – High FRET population; number of bursts increases from white to black. 
Detailed explanation in the text. 
 
Two populations in Figure 3.29 represent examples of a low FRET or donor only population 
(population 1) and a high FRET population (population 2). With the appearance of FRET, the 
ratio between green and red fluorescence (SG/SR) decreases (due to the increase of red 
fluorescence). At the same time, the lifetime of the donor also decreases (due to the energy 
transfer to the acceptor), resulting in the movement of the FRET population along the 
sigmoidal curve (red in Figure 3.29), i.e. toward the lower donor lifetime and lower SG/SR 
ratio.  
 
3.7.1. Conformational changes during DNA binding in the presence of Ca2+ ions 
 
Conformational changes during DNA binding were first monitored using the double labeled 
BsoBI E290C variant and the 12 bp long specific or unspecific oligonucleotide, in the 
presence of Ca2+ ions. The results obtained are presented in Figure 3.30, as 2D frequency 
histogram of SG/SR vs. τD(A). Full trace data underwent a burst selection process, in which only 
the bursts containing >20 photons in the red channel were selected. This selection allowed for 
excluding red bursts not originating from FRET, and it is commonly used to remove 
significant amount of donor-only population. As can be seen in Figure 3.30, this analysis did 
not influence the properties of the FRET species (compare red lines with black and orange 
filled histograms).  
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Figure 3.30 Double labeled BsoBI E290C in the presence of CaCl2 with 12 bp long DNA. 
The ratio between green and red fluorescence (SG/SR) was corrected for background, detection 
efficiencies and crosstalk. Red lines in single histograms represent full trace data; black and 
orange filled histograms represent bursts selected based on the number of photons in the red 
channel – only bursts with more than 20 photons were selected. Red circle – high FRET; blue 
circle – middle FRET. The structure on the left indicates the labeling positions. 
 
Double labeled (Alexa488/Alexa647) BsoBI E290C was diluted to 50 pM in buffer 
containing CaCl2, and measured in the absence of DNA for 1,5 h. The results obtained 
presented in Figure 3.30 show that BsoBI E290C has one favored conformation in the absence 
of DNA (left panel), with a second conformation present in low proportion (around 7 %, 
according to the probability distribution analysis – PDA [71]). This population has the same 
distance between the fluorophores as the enzyme with the specific substrate bound. The 
addition of specific DNA (Figure 3.30, middle panel) causes a significant change in 
conformation of BsoBI E290C, which results in almost complete movement (indicated by the 
arrow) of high FRET species to lower FRET value (approximately 12 % of the protein, 
according to the PDA analysis, is still in the high FRET population). The binding of 
unspecific DNA (Figure 3.30, right panel) causes no significant change compared to the 
FRET species of protein alone.  
The same experiments were done using a 39 bp long specific or unspecific DNA, and the 
results are presented in Figure 3.31. As in the previous case, burst selection was performed in 
order to remove donor-only population.  
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Figure 3.31 Double labeled BsoBI E290C in the presence of CaCl2 with 39 bp long DNA. 
The ratio between green and red fluorescence (SG/SR) was corrected for background, detection 
efficiencies and crosstalk. Red lines in single histograms represent full trace data; black and 
orange filled histograms represent bursts selected based on the number of photons in the red 
channel – only bursts with more than 20 photons were selected. Red circle – high FRET; blue 
circle – middle FRET; green circle – lowest FRET. The structure on the left indicates the 
labeling positions.  
 
The binding to the 39 bp specific oligonucleotide (Figure 3.31, left panel) caused similar 
conformational changes as in the case of the 12 bp oligonucleotide, namely the movement of 
high FRET species to the lower values. However, binding to longer unspecific DNA showed 
some significant differences. Three different FRET populations can be seen in the presence of 
unspecific DNA (Figure 3.31, right panel). The highest FRET population (approximately 
17 %, according to the PDA analysis) corresponds to the same FRET population present in 
the case of the protein alone. The middle FRET population is the most populated 
(approximately 61 %, according to the PDA analysis) and corresponds to the population 
present also in the case of protein binding to specific DNA. The lowest FRET population 
(approximately 22 %, according to the PDA analysis) is present only in the case of unspecific 
DNA binding.  
In order to get more insight into conformational changes in the helical domain of BsoBI, the 
same experiments were done using the double labeled (Alexa488/Alexa647) variant A153C. 
Figure 3.32 represents the results of the measurements performed in the presence of CaCl2, 
using short (12 bp) and long (39 bp) specific or unspecific DNA.  
Apo-enzyme Specific DNA Unspecific DNA 
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Figure 3.32 Double labeled BsoBI A153C in the presence of CaCl2 with 12 bp and 39 bp 
long DNA. The ratio between green and red fluorescence (SG/SR) was corrected for 
background, detection efficiencies and crosstalk. Red lines in single histograms represent full 
trace data; black and orange filled histograms represent bursts selected based on the number of 
photons in the red channel – only bursts with more than 20 photons were selected. Red circle – 
high FRET; green circle – middle FRET; blue circle – lowest FRET. The structure on the left 
indicates the labeling positions.  
 
Similar to the experiments using the E290C variant, the A153C variant was diluted to 80 pM 
concentration (the difference in concentrations between two variants was caused by different 
labeling efficiencies) in buffer containing CaCl2, and measured in the absence or presence of 
specific or unspecific short or long DNA. As can be seen in Figure 3.32, left panel, BsoBI 
exists in two conformations in the absence of DNA, one of which is more populated 
(approximately 80 % according to the PDA analysis; lower FRET population). After the 
addition of short specific DNA (Figure 3.32, upper row, middle panel), the high FRET 
population is moved toward the lower value, while the low FRET population is slightly 
moved toward the higher value, making mostly single FRET population position in the middle 
between previously existing populations. The addition of short unspecific DNA (Figure 3.32, 
upper row, right panel), does not lead to a significant change, compared to the apo-enzyme 
(Figure 3.32, left panel).  
The addition of long specific DNA (Figure 3.32, bottom row, left panel) caused a slight 
movement of the high FRET population toward the lower value, as well as low FRET 
Apo-enzyme Specific DNA Unspecific DNA 
12 bp 
39 bp 
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population toward the higher value, although this change is not as pronounced as in the case 
of short DNA, or the variant E290C. The addition of long unspecific DNA (Figure 3.32, 
bottom row, right panel), caused the appearance of a third FRET population, with middle 
FRET efficiency value, present only in the case of long unspecific substrate, similar to the 
results obtained with the variant E290C.  
As a control experiment, the double labeled BsoBI variant E100C was used (Figure 3.33). 
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Figure 3.33 Double labeled BsoBI E100C in the presence of CaCl2 with 12 bp long DNA. 
The ratio between green and red fluorescence (SG/SR) was corrected for background, detection 
efficiencies and crosstalk. Red lines in single histograms represent full trace data; black and 
orange filled histograms represent bursts selected based on the number of photons in the red 
channel – only bursts with more than 20 photons were selected. The structure on the left 
indicates the labeling positions.  
 
It can be seen that the addition of either specific or unspecific short DNA does not cause 
significant changes in the conformation of the helical domain of BsoBI.  
 
3.7.2. Conformational changes during DNA binding and cleavage in the presence of 
Mg2+ ions 
 
Conformational changes during binding and cleavage were monitored using the double 
labeled (Alexa488/Alexa594) BsoBI variants E290C (Figure 3.34) and A153C (Figure 3.35). 
The protein was diluted with a buffer containing Mg2+ ions, which support specific DNA 
cleavage. After measuring the protein alone, excess of specific or unspecific, short or long 
DNA was added, and the measurements were repeated.  
Apo-enzyme Specific DNA Unspecific DNA 
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Figure 3.34 Double labeled BsoBI E290C in the presence of MgCl2 with 12 bp and 39 bp 
long DNA. The ratio between green and red fluorescence (SG/SR) was corrected for 
background, detection efficiencies and crosstalk. Red lines in single histograms represent full 
trace data; black and orange filled histograms represent bursts selected based on the number of 
photons in the red channel – only bursts with more than 20 photons were selected. Red circle – 
high FRET; blue circle – middle FRET; green circle – lowest FRET. The structure on the left 
indicates the labeling positions.  
 
In the experiment using protein alone (Figure 3.34, left panel), similar to the case when CaCl2 
was used, two FRET populations can be seen. However, when MgCl2 is present in the buffer, 
the lower FRET population is slightly more populated (19 % compared to previous 7 %, 
according to the PDA analysis). The largest difference between the two metal ions is seen 
when short specific DNA is added (Figure 3.34, upper row, middle panel): in the case of Mg2+ 
the change in FRET populations is minor, and the lower FRET population is increased from 
19 % to 23 %, according to the PDA analysis. Similar to the Ca2+ measurement, after the 
addition of unspecific short DNA (Figure 3.34, upper row, right panel), there is no significant 
change in FRET populations.  
The addition of long specific DNA (Figure 3.34, bottom row, left panel) causes the 
appearance of three FRET populations. The high and the middle FRET populations 
correspond to the populations seen with protein alone and protein with short specific DNA, 
and the low FRET population is not present in the case of short DNA, but only with the long 
DNA. When unspecific long DNA is added (Figure 3.34, bottom row, right panel), the middle 
FRET population seen in the case of long specific DNA is disappearing.  
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The same experiments were repeated with double labeled BsoBI A153C variant, using MgCl2 
and specific or unspecific, short or long DNA (Figure 3.35).  
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Figure 3.35 Double labeled BsoBI A153C in the presence of MgCl2 with 12 bp and 39 bp 
long DNA. The ratio between green and red fluorescence (SG/SR) was corrected for 
background, detection efficiencies and crosstalk. Red lines in single histograms represent full 
trace data; black and orange filled histograms represent bursts selected based on the number of 
photons in the red channel – only bursts with more than 20 photons were selected. Red circle – 
high FRET; green circle – middle FRET; blue circle – lowest FRET. The structure on the left 
indicates the labeling positions.  
 
BsoBI A153C apo-enzyme diluted in buffer containing MgCl2 exists in at least two 
populations, with different FRET values, similarly to the previously described experiments in 
the presence of CaCl2. As in the case of variant E290C, the addition of short specific DNA 
does not cause significant changes in FRET populations, when Mg2+ ions are present in the 
buffer. Also, the addition of short unspecific DNA does not cause a significant change.  
The addition of long specific DNA causes the appearance of a third FRET population, with 
the value between the values seen in the apo-enzyme. This middle value FRET population is 
also present in the case of long unspecific DNA, although it is less populated.  
The control experiment using BsoBI E100C variant did not show any significant difference in 
FRET populations when different substrates were added to the protein (Figure 3.36).  
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Figure 3.36 Double labeled BsoBI E100C in MgCl2 with 12 bp long DNA. The ratio between 
green and red fluorescence (SG/SR) was corrected for background, detection efficiencies and 
crosstalk. Red lines in single histograms represent full trace data; black and orange filled 
histograms represent bursts selected based on the number of photons in the red channel – only 
bursts with more than 20 photons were selected. The structure on the left indicates the labeling 
positions.  
 
An overview of conformational changes in BsoBI A153C and E290C during DNA binding 
and cleavage, studied on the single-molecule level is presented in Figure 3.37.  
 
 
Figure 3.37 Overview of the single-molecule experiments. 
 
Apo-enzyme Specific DNA Unspecific DNA 
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4. Discussion 
 
Restriction endonucleases are important for every day laboratory work, as they are essential 
for all genetic engineering techniques. Along with their practical use, they are also model 
systems for studying protein/DNA interactions, and one of the best studied families of 
proteins/enzymes. The ability to control their activity, change the specificities or selectively 
activate/deactivate restriction enzymes could be one of the approaches to gene targeting and 
gene therapy. In order to do that, we have to understand all aspects of their functions, 
including the means of finding their recognition site or possible conformational changes in 
enzyme and/or DNA during the substrate binding and cleavage. The main aim of this work 
was to investigate conformational changes of the thermostable Type IIP restriction enzyme 
BsoBI, during substrate binding and cleavage. Different fluorescence techniques were chosen, 
because of their high sensitivity and possibility to observe distance changes in the range that 
is relevant for most of the biological functions. These techniques also allowed the monitoring 
of BsoBI conformational dynamics during the catalytic process.  
 
4.1. Creating catalytically inactive single-cysteine BsoBI variants 
 
The influence of DNA binding without cleavage in the presence of Mg2+ ions can be studied 
using different approaches, e.g. using an unspecific (non-cleavable) substrate or creating a 
cleavage inactive but binding active variant of the enzyme. In order to create cleavage 
inactive variants, certain residues in the catalytic center of the enzyme have to be mutated. 
Based on available literature data [36] two positions were chosen: aspartic acid at position 
212 and histidine at position 253. The role of histidine as a putative catalytic residue [38] was 
not seen in any other restriction enzyme so far. Newly created BsoBI variants D212N, D212A 
and H253Q were checked for binding and cleavage activity, and it was shown that exchange 
of histidine at the position 253 to glutamine leads to loss in both binding (Figure 3.2) and 
cleavage activity (Figure 3.3). On the contrary, the exchange of aspartic acid at position 212 
to asparagine resulted in preservation of the binding activity (Figure 3.2), but caused a loss of 
the cleavage activity (Figure 3.3).  
Thus, the newly created BsoBI variant D212N could be used to examine the binding of 
specific DNA in the presence of Mg2+ ions without cleavage occurring. However, the 
mutation was introduced in the active site, the place most likely involved in metal ion binding. 
As was shown previously, and will be discussed in the next chapters, there is a strong 
influence of different divalent metal ions on the structure of BsoBI, as well as on the kinetics 
of its catalytic cycle. For this reason, the use of a variant with modified metal ion binding site 
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would be inappropriate, since it would not give a clear picture of the catalytic properties of the 
wild type enzyme.  
 
4.2. Michaelis-Menten kinetics 
 
Michaelis-Menten kinetics describe the rate of enzyme catalyzed reactions, when the product 
does not bind to the enzyme, and the concentration of the substrate is higher than the 
concentration of the enzyme. In order to accurately determine kinetic parameters, the 
substrate concentration is increased until a constant rate of product formation is achieved 
(maximum velocity, Vmax). Different factors can affect the rate of enzymatic reactions, such as 
pH or temperature. In this study, the effect of different temperatures on the kinetic parameters 
of BsoBI was analyzed. BsoBI is a thermostable restriction enzyme, with an optimal catalytic 
activity at 65 °C. However, all ensemble and single-molecule experiments were carried out at 
room temperature (25 °C). The kinetic parameters were calculated for three different 
temperatures, 25 °C, 37 °C and 65 °C, in order to determine how the kinetic constants were 
affected by the change in temperature.  
As can be seen in Figure 3.4 and Table 7, the change in temperatures did not significantly 
influence the cleavage rate (kcat) of BsoBI. In contrast, the value of the Michaelis constant 
(KM) decreased with the increase of temperature. The Michaelis constant is a measure of the 
affinity of an enzyme to the substrate; the higher KM is, the lower the affinity of the enzyme 
for its substrate. This result suggests that the temperature affects the conformation of BsoBI, 
by slowing down the conformational changes prior to substrate binding at lower temperatures. 
The observed behavior can explain the existence of two distinct FRET populations seen in 
single-molecule experiments (Chapter 4.6.). At higher temperatures conformational changes 
of BsoBI would be faster, and different FRET subpopulations might not be resolved, because 
of their short lifetime. Since the single-molecule experiments were carried out at room 
temperature, the speed of conformational changes was slow enough to allow the observation 
of distinct subpopulations.  
 
4.3. Site-specific fluorescent labeling of selected single-cysteine BsoBI variants 
 
In order to perform the desired experiments, a set of single-cysteine variants of BsoBI had to 
be created, and labeled with different fluorophores using maleimide chemistry. The distance 
between these positions and the fluorophores chosen had to be suitable for ensemble as well 
as for single-molecule FRET experiments. The positions chosen had to be surface exposed 
and mutations at these positions or the introduction of fluorophores should not influence the 
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binding or cleavage activity of the enzyme. It was shown that exchange of amino acids at 
positions chosen to cysteines (Figure 3.1) or fluorescent labeling at these positions (Figure 
3.8) did not influence the cleavage activity of BsoBI.  
Based on previous cross-linking data (see below), it was suggested that BsoBI undergoes 
conformational changes in its catalytic domain. Therefore, two positions were chosen in this 
part of the enzyme, with suitable distances, to monitor the conformational changes upon 
substrate binding and cleavage: A153 and E290 (Figure 3.5). These positions are located in 
different protein axes, and by combining the results from both positions it was possible to 
resolve the directions of conformational changes. In addition to these positions, two more 
positions were chosen for exchange into cysteines, namely S298 and R318. In the case of the 
single-cysteine variant S298C no significant change in FRET signal was observed upon DNA 
binding. The FRET change of the double labeled R318C variant was the same as in the case 
of the A153C variant. Therefore, the variants A153C and E290C were chosen as the best 
representatives to study the conformational change of BsoBI. As a control, one position on the 
helical domain of the enzyme was chosen (E100, Figure 3.5), because it was assumed that this 
part of the enzyme does not change its conformation upon substrate binding or cleavage.  
The choice of fluorophores depended on the distance between the labeling positions, as well 
as their suitability for different experiments. Initially, Alexa488 C5 maleimide and Alexa594 
C5 maleimide were chosen as donor and acceptor fluorophores, respectively. After initial 
single-molecule experiments it was suggested that, based on the set-up available, Alexa647 C2 
maleimide is used as acceptor, since the cross-talk between donor and acceptor is smaller, and 
the quality of the results would be better.  
Since BsoBI is a homodimer, the introduction of cysteine in one subunit leads to the 
introduction of the cysteine to the same position in the other subunit. Random labeling with 
the mixture of donor and acceptor fluorophore would give the ratio of 1:2:1 of donor labeled : 
donor/acceptor labeled : acceptor labeled molecules. Single-molecule experiments required 
better labeling quality, preferably only molecules with donor fluorophore on one subunit and 
acceptor fluorophore on the other subunit, although single-molecule measurements allow 
separation of different species, and thus it could be possible to separate differently labeled 
enzymes. If the sample has too much donor only labeled molecules, the measurements should 
be performed for longer times, in order to achieve satisfactory statistics, which is not always 
possible if the enzyme is not stable. Also, the excess of unreacted fluorophore had to be 
removed after the labeling reaction. The labeling protocol was modified from the one 
available in the literature [72]. The enzyme was first labeled with the donor fluorophore, and 
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differently labeled molecules (single, double or unlabeled) were separated using anion 
exchange chromatography. An important step in this process was choosing the optimal pH 
value, at which the protein binds to a positively charged anion exchanger. This pH value had 
to be higher than the isoelectric point (pI) of the protein, which was estimated to be around 
7.5. Since the fluorophores are negatively charged, introduction of one or two fluorophores 
introduces one or two additional negative charges to the protein, respectively. During elution 
from the anion exchange column, molecules with the lowest negative charge are eluted first 
(unlabeled protein), followed by protein labeled with one and two fluorophores. The elution 
was done by increasing the ionic strength (salt concentration) of the buffer, allowing the salt 
ions to compete for charges on the column with bound components, and thus eluting them 
from the column. Although no complete separation was achieved (Figure 3.9c), the removal 
of most of the donor only double labeled molecules was successful. Also, certain amounts of 
acceptor only double labeled molecules was produced, but this population was not “visible” in 
single-molecule experiments, since the excitation was done at the wavelength of the donor 
fluorophore.  
This labeling protocol produced enough material for single-molecule experiments, but not for 
stopped-flow experiments. Since the pure double labeled protein was not needed for these 
experiments, BsoBI was randomly labeled with mixture of donor and acceptor fluorophore, 
and the anion exchange chromatography was excluded from the protocol, since it is the step 
during which most of the material is lost.  
 
4.4. DNA binding induces conformational change in the catalytic domain of 
BsoBI 
 
Based on the available co-crystal structure it was clear that the helical domain of BsoBI is 
more compact than the catalytic domain, and that the catalytic domain probably undergoes 
large conformational change in order to allow DNA entry. This was confirmed in previous 
cross-linking experiments (Diploma thesis Katja Welsch, Justus-Liebig-University Gießen, 
2006). However, the directions of conformational changes, as well as their kinetics, were not 
known. After producing the single-cysteine variant A153C, it was expected that the distance 
between two fluorophores decreases after DNA binding, if the conformational change was 
simple “opening” (in a scissor-like movement) of the catalytic domain. However, steady-state 
FRET experiments showed that upon DNA binding the FRET efficiency decreases in 
comparison to the apoenzyme (Figure 3.10a). This result showed that two fluorophores at the 
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position A153 move apart upon specific DNA binding, in the presence of Ca2+ ions, which 
support only specific substrate binding, but not cleavage.  
The binding of unlabeled specific DNA to the double labeled BsoBI variant E100C did not 
cause a significant change in the FRET signal (Figure 3.11a). This result showed that there is 
no major movement of the helical domain of BsoBI upon substrate binding in the presence of 
Ca2+ ions.  
Steady-state FRET experiments revealed an unusual influence of different divalent metal ions 
on the conformation of the catalytic domain of BsoBI. It was shown that the presence of Ca2+ 
ions induces an increase of the FRET signal of the double labeled BsoBI apoenzyme, in 
comparison to the presence of Mg2+ or EDTA (Figure 3.13a). This suggested that the 
fluorophores at the position A153 move closer together when Ca2+ is present in the solution, 
while in the presence of Mg2+ or EDTA they move apart. In the case of the position E100, no 
significant change in FRET values was observed in the presence of either metal ion (Figure 
3.13b). The influence of Ca2+ ions on the conformation of catalytic domain of BsoBI was also 
studied by titrating different CaCl2 concentrations to the double labeled BsoBI A153C 
apoenzyme. This allowed determining the binding constant of Ca2+ to BsoBI, which was 
estimated to be ~ 1 mM (Figure 3.14).  
 
4.5. Kinetic studies of BsoBI substrate binding and cleavage – influence of Ca2+ 
and Mg2+ ions 
 
The observed changes in the catalytic domain of BsoBI after DNA binding were monitored in 
pre-steady state experiments, using the double labeled BsoBI variant A153C and unlabeled 
DNA, mixed in the presence of Ca2+ ions. This allowed monitoring the kinetics of the 
conformational changes upon specific DNA binding. After mixing double labeled BsoBI with 
unlabeled DNA, and monitoring the change in the donor signal, it was seen that the donor 
signal increases over time, as expected based on previous steady-state experiments (Figure 
3.15). Different concentrations of DNA were used, in order to globally analyze the kinetic 
traces and resolve different steps during DNA binding. Specific DNA binding in the presence 
of Ca2+ can be described as a two step reaction: a first order conformational change prior to 
DNA binding (with an equilibrium constant of 1.5), followed by a second order association of 
DNA (with a rate constant of 0.5 μM-1s-1). These experiments also revealed the presence of 
two conformations of BsoBI in the solution, only one of which is believed to be binding 
competent (referred to as E2).  
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The kinetics of DNA binding was also monitored using single (donor) labeled BsoBI and 
single (acceptor) labeled specific DNA, in the presence of Ca2+ ions. As in the previous 
experiment, the enzyme concentration was kept constant while the DNA concentration varied. 
The changes in donor signal were monitored, since the concentration of donor labeled species 
was constant during the series of experiments. The binding of acceptor labeled DNA to donor 
labeled enzyme caused appearance of FRET and subsequent decrease of donor signal over 
time (Figure 3.16). Again, the experimental curves obtained were fitted globally in order to 
resolve single steps during specific DNA binding. The analysis showed the presence of two 
conformations of BsoBI (with an equilibrium constant of 0.6), one of which is competent to 
bind DNA (E2), and DNA binding is described by a second order association with a rate 
constant of 0.2 μM-1s-1. The rate constants for DNA binding obtained in these experiments 
slightly differ from the rate constants obtained in the experiments with double labeled BsoBI, 
which could be explained by fluorophores now being on both enzyme and DNA.  
The full catalytic cycle of DNA binding, cleavage and product release was monitored using 
single (donor) labeled BsoBI and single (acceptor) labeled specific DNA. They were mixed in 
the presence of Mg2+, i.e. conditions that allow specific DNA binding and cleavage. The 
protein concentration was constant, while DNA concentration was varied during the series of 
experiments, so the changes in donor signal were monitored. After rapid mixing of donor 
labeled enzyme and acceptor labeled DNA, there is a decrease in donor signal over time, due 
to DNA binding and appearance of FRET. After DNA cleavage, acceptor labeled product is 
released, which results in the disappearance of FRET and the concomitant increase in donor 
signal (Figure 3.17). The experimental curves obtained were fitted globally in order to resolve 
single steps of DNA binding, cleavage and product release. The analysis showed the presence 
of two conformations of BsoBI before DNA binding, similar to the previously described 
experiments. This time, the changes are faster than in the presence of Ca2+, which can be 
explained by different influences of these two metal ions already observed in steady-state 
experiments. DNA binding is described as a second order association, with a rate constant of 
4.8 μM-1s-1, approximately 20 times faster than in the presence of Ca2+. These results show 
that binding of DNA in the presence of Ca2+ is slower than in the presence of Mg2+, 
presumably by Mg2+ favoring a binding competent conformation of BsoBI. The observed rate 
constant of cleavage of 0.6 s-1 is in good agreement with rates usually observed for other 
restriction enzymes (REBASE Kinetics Data, http://rebase.neb.com/cgi-bin/kinlist). Cleavage 
of DNA is slower than the product release (estimated 2.2 s-1), suggesting that cleavage, and 
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not the product release, is the rate limiting step in the BsoBI catalytic cycle under these 
conditions.  
The exchange of different divalent metal ions causes a conformational change in the apo-
enzyme, which is reflected in the change of the FRET signal of the double labeled BsoBI 
A153C variant. The addition of MgCl2 to BsoBI diluted in buffer containing CaCl2 causes a 
decrease in the FRET signal (Figure 3.18), suggesting conformational changes that move two 
fluorophores at the 153 positions further apart. In contrast, the addition of CaCl2 to BsoBI 
diluted in buffer containing MgCl2 causes an increase in FRET signal (Figure 3.21), 
suggesting a conformational change of the double labeled apo-enzyme that moves the two 
fluorophores at the 153 positions closer together. While the lowest concentration of MgCl2 
(orange curve in Figure 3.18) does not cause significant changes in the acceptor signal, the 
lowest concentration of CaCl2 (orange curve in Figure 3.21) causes significant changes in the 
FRET signal of the apo-enzyme previously diluted in buffer containing the same 
concentration of MgCl2. This result suggests that the affinity of Ca2+ ions to the BsoBI apo-
enzyme is greater than the one of Mg2+ ions.  
The influence of Mg2+ and Ca2+ ions on DNA cleavage by BsoBI was further investigated 
using different mixtures of these two ions. When donor labeled BsoBI and acceptor labeled 
DNA were pre-bound in the presence of 0.5 mM EDTA and mixed with different ratios of 
CaCl2 and MgCl2, two effects were observed (Figure 3.26). After addition of equal 
concentrations of both metal ions, residual substrate binding followed by very slow cleavage 
was observed. This result showed that in the presence of the same concentrations of metal 
ions, Ca2+ ions bind firmly to the enzyme, preventing Mg2+ ion binding, and consequently 
interfering with (or at least slowing down) DNA cleavage. In contrast, when excess of Mg2+ 
over Ca2+ ions is present, fast cleavage of DNA is observed, showing that higher 
concentrations of MgCl2 (in comparison to CaCl2) are needed for Mg2+ to bind to the enzyme 
and for cleavage of the DNA to occur. So far, without more experiments that would include 
different ratios of CaCl2 and MgCl2, it is not possible to resolve different steps in the metal 
ion exchange reaction. A possible scheme of this reaction is presented below, showing the 
binding of both metal ions to the enzyme/substrate complex, although from the experiments 
described it cannot be concluded if dissociation of substrate is necessary before binding of 
different metal ions.  
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2 E.S E.S.Mg, E.S.Ca E.S.Ca, E.P.Mg E.Mg + P
Mg2+
Ca2+ E.S.Ca
 
The influence of different MgCl2 concentrations on the cleavage of DNA pre-bound to BsoBI 
in the presence of EDTA is shown in Figure 3.27. The lowest concentration of MgCl2 
(5.5 mM) causes a lag of the monitored signal, during which Mg2+ ions bind to the 
enzyme/DNA complex. After this, the cleavage of DNA and subsequent product release can 
occur, which is reflected in the increase of the donor signal (black curve in Figure 3.27). The 
addition of higher MgCl2 concentration causes very fast DNA cleavage, which is unresolved 
in the dead-time of the machine. Again, without additional MgCl2 concentrations it is not 
possible to resolve different reaction steps, but one possible reaction scheme is presented 
below. It is also unclear if the dissociation of substrate is necessary for the Mg2+ ions to bind 
and allow DNA cleavage to occur.  
E.S E + S E.S.Mg E.P.Mg E.Mg + P
Mg2+
 
Finally, the influence of different MgCl2 concentrations on DNA cleavage was monitored 
after pre-mixing BsoBI and specific DNA in the presence of 5.5 mM CaCl2 (Figure 3.28). The 
addition of equal concentrations of MgCl2 (black curve in Figure 3.28) was not enough to 
replace all Ca2+ ions, and caused only very slow DNA cleavage, confirming previous 
observations that Ca2+ ions have a greater affinity for BsoBI than Mg2+ ions. Only when 
excess of MgCl2 was added, it was possible to replace Ca2+ ions from the enzyme/DNA 
complex and allow DNA cleavage (red curve in Figure 3.28). Like in previous experiments, 
the lack of data with different MgCl2 concentrations limits the possibility to resolve different 
reaction steps and to predict different rate constants. It remains unclear if the dissociation of 
substrate is a necessary step in this reaction, and a possible scheme is presented below.  
E.S.Ca E.S E.S.Mg E.P.Mg E.Mg + P
Mg2+
Ca2+
koff
E + S
 
The experiments described clearly show different effects of Mg2+ and Ca2+ ions on the 
catalytic activity of BsoBI. The presence of Mg2+ speeds up the equilibrium between two 
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BsoBI conformations, as well as faster DNA binding. The different metal ions also showed an 
unusual influence on the conformation of the apo-enzyme, which could be followed as the 
change of FRET efficiency of double labeled BsoBI. These experiments also revealed unusual 
differences in affinities of Ca2+ and Mg2+ ions, showing that the affinity of Ca2+ ions to BsoBI 
is greater than the one of Mg2+. The confirmation of these findings was shown in the 
experiments analyzing the influence of mixtures of two metal ions on the DNA cleavage, 
which needs to be looked at in greater detail. Moreover, the use of mixtures of two metal ions 
causes the presence of enzymes containing both metal ions bound to the metal ion binding 
sites at the same time, which additionally complicates the analysis and interpretation of the 
results obtained.  
 
4.6. Conformational changes in BsoBI during DNA binding and cleavage studied 
on the single-molecule level 
 
Previously observed influences of DNA binding or metal ions on the conformation of BsoBI 
were the result of different ensemble experiments. In these experiments subpopulations 
present in the sample cannot be seen, and all effects are the result of averaging of different 
signals. In order to resolve the subpopulations hidden in the average signal, several series of 
single-molecule experiments were done using single-molecule multiparameter fluorescence 
detection (smMFD). In these experiments, double labeled BsoBI molecules were freely 
diffusing through the solution, and 8 different fluorescence parameters were monitored: 
excitation spectrum, fluorescence spectrum, fundamental anisotropy, fluorescence lifetime, 
FRET, fluorescence quantum yield, fluorescence intensity and time. Combination of different 
parameters allowed for separating subpopulations of molecules present in the sample.  
The single-molecule measurements of the double labeled BsoBI A153C variant, in the 
presence of CaCl2, revealed the existence of at least two populations of apo-enzyme, with 
different FRET values (Figure 3.32). These two populations are most likely the same as those 
observed in pre-steady state experiments, described as DNA binding competent and DNA 
binding incompetent conformations. The addition of a short specific DNA causes a shift in 
FRET populations, so that the population with lower FRET is more populated (Figure 3.32). 
This suggests that the two fluorophores at the positions 153 move apart after DNA binding, as 
it was shown in the steady-state ensemble measurements. The addition of short unspecific 
DNA did not cause any significant change in FRET populations, presumably because of the 
low affinity of BsoBI for the short unspecific substrate. These results suggest that the lower 
FRET population represents a binding incompetent conformation of BsoBI, as well as DNA 
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occupied conformation, while the population with higher FRET represents a binding 
competent conformation. Similarly to the experiments using short substrate, the addition of 
long specific DNA causes the movement of FRET species towards the lower value, although 
not as pronounced as with short DNA (Figure 3.32). However, the addition of long unspecific 
DNA causes the appearance of additional FRET populations. These subpopulations represent 
different binding modes of BsoBI to the long unspecific substrate, where it can bind to several 
different positions on the DNA and take up slightly different conformations.  
In contrast to the variant A153C, the apo-enzyme E290C apparently exists in mainly one 
FRET population in the presence of CaCl2 (Figure 3.30). However, this result does not mean 
that the BsoBI variant E290C exists in only one conformation, but that two conformations 
seen with the A153C variant have the same FRET value when 290 position is chosen for 
labeling. The addition of short specific DNA caused a shift in FRET populations towards the 
lower FRET value, suggesting conformational changes of the catalytic domain of BsoBI that 
moves two fluorophores at the position 290 further apart. The addition of a short unspecific 
DNA, similar to the variant A153C, did not cause the significant change in FRET populations. 
The binding of a long specific substrate (Figure 3.31) caused the same conformational change 
as the short specific substrate, i.e. a shift towards the lower FRET value. However, the 
addition of long unspecific substrate caused the appearance of an additional FRET population, 
with the lowest FRET value. These populations represent different binding modes of BsoBI to 
the long unspecific substrate, presumably the conformations of the enzyme while searching 
for its recognition site.  
In order to investigate the conformational changes during substrate binding and cleavage, 
single-molecule experiments were carried out in the presence of MgCl2, the metal ion which 
allows specific DNA cleavage to occur. Under these conditions, the observed conformations 
of BsoBI represent different states of the enzyme, i.e. substrate or product bound states, or 
free enzyme. That substrate bound states are seen at all is due to the fact that substrate is in 
large excess over enzyme, which is present at very low concentration.  
The FRET populations of the BsoBI E290C apo-enzyme did not change significantly when 
MgCl2 is used instead of CaCl2 (Figure 3.34). In contrast, the most striking difference is seen 
when the substrate is added to the enzyme in the presence of Mg2+ ions. The addition of short 
specific DNA caused a small shift in FRET populations, towards the lower FRET value, in 
contrast to the CaCl2 conditions, when the shift is almost complete. As previously mentioned, 
in the presence of MgCl2, different enzyme-substrate complexes can be observed. However, 
the affinity of BsoBI for the product derived from the short substrate cleavage is very low, 
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and thus this conformation is not very populated, and the predominant conformation seen in 
this experiment is that of the free enzyme. As in the case of CaCl2 conditions, the addition of 
short unspecific DNA does not cause a significant change in FRET populations compared to 
the apo-enzyme. The addition of a long specific DNA causes the appearance of a new 
population, with the lowest FRET value observed in this experiment (Figure 3.34). This 
population may represent one of the binding modes of BsoBI to the long substrate, not present 
in the case of a short substrate, where BsoBI has only one binding position. In addition to this 
population, the populations of free enzyme (high FRET value) and substrate/product bound 
enzyme are also present (middle FRET value). In the presence of long unspecific DNA, as 
expected, the population of product bound enzyme (middle FRET value) is not present, and 
only populations of free enzyme and of the unspecific complex are present.  
The BsoBI A153C apo-enzyme measured in the presence of Mg2+ ions exists in at least two 
populations (Figure 3.35), with the lower FRET population slightly more populated compared 
to the CaCl2 conditions. As in the case of the E290C variant, the addition of a short specific 
DNA does not cause a significant shift in FRET populations (as was also shown in the steady-
state ensemble experiments [Figure 3.10b]), presumably because of the low affinity of BsoBI 
to the product of the cleavage of a short substrate. Also, the addition of a short unspecific 
substrate did not cause significant changes in FRET values compared to the apo-enzyme. The 
addition of a long specific substrate, in the presence of Mg2+ ions, causes the appearance of a 
middle FRET value population, presumably representing a product bound state of the enzyme. 
This population is not as pronounced when the unspecific substrate is present, although 
several FRET populations are visible, representing different binding modes of BsoBI to the 
long unspecific substrate. 
As a control, single-molecule experiments were performed using the double labeled BsoBI 
E100C variant, which has single cysteines introduced in the helical domain of the enzyme. 
Based on previous experiments and available literature data, it was expected that this part of 
the enzyme does not change its conformation upon substrate binding. The single-molecule 
experiments confirmed this assumption (Figure 3.33, Figure 3.36), since there is no 
significant shift in the FRET population after adding specific or unspecific substrate.  
The single-molecule experiments confirmed the influence of substrate binding to the 
conformation of the catalytic domain of BsoBI. Also, they revealed the existence of at least 
two subpopulations of the apo-enzyme, which could be quantitatively analyzed. It was shown 
that the binding of long unspecific substrate induces the appearance of more subpopulations, 
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representing different binding modes to the long substrate, presumably during the search for 
the recognition site.  
Based on the single-molecule experiments described, a model for conformational changes 
ocurring in BsoBI upon divalent metal and DNA binding can be proposed (Figure 4.1), which 
assumes a complex “twisting” motion of two subunits, which leads to a closer distance 
between residues 153 and 290 in the apo-enzyme compared to the substrate bound complex. 
The results obtained suggest that the “simple” scissor-like movement of BsoBI subunits is not 
likely, since the distances between residues 153 and 290 would be larger in the apo-enzyme.  
 
 
Figure 4.1 A scheme illustrating BsoBI conformational changes. The apo-enzyme exists in at 
least two conformations, binding competent and binding incompetent. The distances between 
residues 153 of the two subunits and 290 of the two subunits are shorter in the apo-enzyme than 
in the DNA-bound complex. 
The combination of single-molecule experiments and ensemble steady-state and pre-steady 
state experiments, allowed the determination of individual steps in the catalytic cycle of 
BsoBI, and the analysis of the effects of different metal ions on this process. However, more 
detailed experiments are needed to fully describe the influence of Ca2+ and Mg2+ metal ions. 
Also, the use of more single-cysteine variants will allow a more accurate modeling of the 
conformational changes in the catalytic domain of BsoBI.  
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5. Summary 
 
Enzyme flexibility is known to be crucial for various enzymatic functions: allosteric 
regulation, catalysis or ligand binding induced conformational changes. Conformational 
rearrangements have wide range of timescales, and are considered intrinsic features of all 
proteins. X-ray crystallography has provided important insight into different enzymatic 
conformations, but it can only give a snapshot of a complex protein life cycle. Fluorescence 
spectroscopy methods are becoming the primary methods in investigating protein structural 
dynamics, especially when combined with different single-molecule techniques.  
Restriction endonucleases are important tools for every day laboratory work, being essential 
for all genetic engineering techniques. They are also model systems for studying protein/DNA 
interactions and one of the best studied families of proteins/enzymes. The main aim of this 
study was to investigate conformational changes of restriction enzyme BsoBI, during 
substrate binding and cleavage. Fluorescence resonance energy transfer (FRET) was used to 
determine the changes in distances between donor and acceptor fluorophores during substrate 
binding and cleavage, in steady-state or pre-steady state ensemble, as well as in single-
molecule experiments. These fluorophores were attached to single cysteine residues 
introduced to BsoBI subunits at specific positions.  
BsoBI is a thermostable restriction enzyme, with optimal catalytic activity at 65 °C. 
Crystallographic studies had shown that BsoBI exists as a homodimer, which completely 
encircles specific DNA. The substrate is enclosed in a 20 Å long tunnel formed by the protein, 
which excludes access of water molecules from the solvent. Up to date, only the co-crystal 
structure of BsoBI with specific DNA is known, and there are no data indicating the 
conformational changes required for substrate binding and cleavage. The crystallographic data 
had shown that the interface between the catalytic domains of BsoBI is much weaker than the 
one between the helical domains, and it was proposed that the major conformational changes 
happen in the catalytic domain of the enzyme.  
Steady-state experiments using double labeled BsoBI confirmed that the binding of DNA 
causes a conformational change in the catalytic domain of the enzyme. The addition of 
unlabeled specific DNA to the double labeled BsoBI variant A153C (positioned at the 
catalytic domain) caused a decrease in FRET signal. This result unexpectedly suggested that 
the fluorophores at the 153 position move apart upon specific substrate binding. The addition 
of DNA to the double labeled BsoBI variant E100C (positioned at the helical domain) did not 
cause change in the FRET signal, suggesting that this part of the enzyme does not change its 
conformation upon substrate binding. Suggested conformational change in the catalytic 
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domain of BsoBI does not involve expected scissor-like motion of two subunits, but more 
complex “twisting” motion. These experiments also showed the influence of Ca2+ and Mg2+ 
ions on the conformation of the catalytic domain of BsoBI. The presence of Ca2+ induced a 
conformational change of the catalytic domain of the enzyme that moved two fluorophores at 
the positions 153 closer together, while the presence or the absence of Mg2+ did not cause any 
effect on the BsoBI conformation.  
The conformational changes during substrate binding and cleavage, as well as the influence of 
different metal ions were analysed in pre-steady state experiments, using double labeled 
BsoBI and unlabeled DNA, or single labeled BsoBI and DNA. These experiments also 
confirmed the influence of DNA binding on the conformation of the catalytic domain of 
BsoBI. In addition, the kinetic model of DNA binding and cleavage revealed the existence of 
at least two conformations of the free enzyme before DNA binding. These two conformations 
were proposed to be substrate binding competent and substrate binding incompetent. The 
kinetic models also suggested that BsoBI binds Ca2+ and Mg2+ with different affinity, namely 
that Ca2+ binding is stronger and faster than Mg2+ binding.  
The single-molecule experiments confirmed the existence of at least two different 
conformations of the apo-enzyme, and allowed quantifying the relative proportions of these 
subpopulations. The analysis of single-molecule experiments using different time windows 
demonstrated slow dynamics of different conformations of apo-enzyme, which was expected 
based on the observed influence of temperature on the KM value of BsoBI. Also, it was shown 
that the enzyme has more than one conformation when bound to the unspecific long substrate, 
suggesting different binding modes to the unspecific DNA.  
By combining different fluorescence techniques, as well as different single cysteine variants, 
it was possible to explain and model single the conformational dynamics of substrate binding 
and cleavage by BsoBI. These experiments showed unexpected mechanism of the 
conformational changes, as well as the influence of different metal ions on the conformation 
of BsoBI.  
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6. Zusammenfassung 
 
Die Flexibilität von Enzymen ist essentiell für verschiedene enzymatische Aufgaben, z.B. die 
allosterische Regulation, die Liganden- und Substratbindung sowie die eigentliche Katalyse. 
Diese Konformationsänderungen können dabei unterschiedliche Zeitskalen aufweisen, und 
werden als eine intrinsische Eigenschaft aller Proteine angesehen. Die Röntgenstrukturanalyse 
hat wichtige Erkenntnisse über diese unterschiedlichen Konformationen verschiedenster 
Enzyme geliefert, sie ermöglicht jedoch immer nur eine Momentaufnahme im komplexen 
Katalyseprozess. Es werden daher heutzutage vermehrt fluoreszenzspektroskopische 
Methoden, insbesondere moderne Einzelmolekültechniken eingesetzt, um die strukturelle 
Dynamik von Proteinen zu untersuchen. 
Restriktionsendonukleasen sind wichtige Werkzeuge im molekularbiologischen Labor und 
essentiell für Anwendungen in der Gentechnik. Sie dienen jedoch auch als Modelsystem um 
Protein / DNA- Wechselwirkungen zu untersuchen und gehören deshalb zu den am besten 
untersuchten Enzymfamilien. Das Ziel dieser Arbeit war es, die Konformationsänderungen 
der Restriktionsendonuklease BsoBI beim Binden und Spalten der DNA zu untersuchen. 
Hierzu wurden ortsspezifisch einzelne Cysteinreste in beide Untereinheiten des Proteins 
eingebracht und diese mit spezifischen Fluoreszenzfarbstoffen modifiziert. Untersuchungen 
des Fluoreszenz-Resonanzenergietransfers (FRET) zwischen Donor- und Akzeptorfluorophor 
ermöglichten, die Abstandsänderungen der Proteinuntereinheiten beim Binden und Spalten 
der DNA zu detektieren. Die kinetischen steady-state und pre-steady-state Experimente 
wurden dabei im Ensemble durchgeführt und durch fluoreszenzspektroskopische 
Einzelmolekülmessungen ergänzt. 
BsoBI ist ein thermostabiles Restriktionsenzym mit einem Temperaturoptimum für die 
katalytische Aktivität von 65 °C. Die Röntgenstrukturanalyse eines BsoBI x DNA-Komplexes 
hat gezeigt, dass das Protein als Homodimer die spezifische DNA vollständig umschließt. Das 
Substrat liegt dabei in einem 20 Å langen Tunnel, der durch das Protein gebildet wird und die 
Aufnahme von Wasser aus dem Lösungsmittel verhindert. Bis heute ist nur die 
Kokristallstruktur des BsoBI x DNA-Komplexes bestimmt worden, aus der jedoch keine 
Hinweise auf die notwendigen Konformationsänderungen des Enzyms beim Binden und 
Spalten der DNA gezogen werden können. Die kristallographischen Daten zeigen nur, dass 
das Interface zwischen den beiden katalytischen Domänen, im Vergleich zu den beiden 
helikalen Domänen, wesentlich schwächer ausgebildet ist. Aufgrund dessen wurde vermutet, 
dass hauptsächlich Konformationsänderungen der beiden katalytischen Domänen die 
Substratbindung ermöglichen. 
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Steady-state FRET-Experimente mit doppelt markierten BsoBI bestätigten, dass die Bindung 
an die spezifische DNA eine Konformationsänderung zwischen den beiden katalytischen 
Domänen bewirkt. Die Zugabe von spezifischer DNA zu der in der katalytischen Domäne 
doppelt markierten BsoBI Variante A153C verursacht dabei eine Abnahme des FRET-
Effekts. Dieses Ergebnis weist darauf hin, dass sich beim Binden der spezifischen DNA die 
Fluorophore an Position 153 voneinander entfernen. Bei der in der helikalen Domäne 
markierten BsoBI Variante E100C ändert sich der FRET-Effekt bei der Zugabe spezifischer 
DNA nicht; dies deutet darauf hin, dass in diesem Bereich keine Konformationsänderung 
stattfindet. Die steady-state FRET-Experimente machen auch den Einfluss der zweiwertigen 
Metallionen Ca2+ und Mg2+ auf die Konformation der katalytischen Domäne deutlich. Ca2+ 
induziert eine Konformationsänderung der katalytischen Domäne, so dass sich die 
Fluorophore an Position 153 näher kommen. Die Zugabe von Mg2+ hat keinen Effekt auf die 
Konformation von BsoBI. 
Die Konformationsänderung bei der Substratbindung und Spaltung, wie auch der Einfluss der 
Metallionen, wurden darüber hinaus mittels pre-steady-state Experimenten untersucht, bei 
denen doppelt markiertes Protein und unmarkierte DNA oder aber markierte DNA und 
einfach markierte BsoBI Varianten eingesetzt wurden. Diese Experimente bestätigen den 
beobachteten Einfluss der DNA-Bindung auf die Konformation der katalytischen Domäne. 
Des Weiteren konnte mit Hilfe des entwickelten kinetischen Models der DNA-Bindung und 
Spaltung das Vorliegen von mindestens zwei Konformationen des freien Enzyms aufgedeckt 
werden. Eine dieser Konformationen wurde als kompetent, die andere als inkompetent für die 
Substratbindung eingestuft. Die Ergebnisse der pre-steady-state Experimente zeigen auch, 
dass die zweiwertigen Metallionen Ca2+ und Mg2+ mit unterschiedlicher Affinität gebunden 
werden, dabei bindet Ca2+ im Vergleich zu Mg2+ fester und schneller.  
Anschließende fluoreszenzspektroskopische Einzelmolekülmessungen bestätigten schließlich 
die Existenz von zwei unterschiedlichen Konformationen des BsoBI Apoenzyms und 
ermöglichten weiterhin, die relative Größe der beiden Subpopulationen zu quantifizieren. Die 
Analyse der Einzelmolekülmessungen mit Hilfe verschiedener Zeitfenster zeigte eine 
langsame Umwandlung der beiden Konformationen des Apoenzyms bei Raumtemperatur an, 
dies steht im Einklang mit dem beobachtete Einfluss der Temperatur auf die KM-Werte bei 
der Michaelis-Menten-Analyse. Ferner konnten die Einzelmolekülmessungen mehr als eine 
Konformation und somit unterschiedliche Bindungsmodi nachweisen, wenn BsoBI an 
unspezifische DNA bindet.  
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Durch die Kombination unterschiedlicher fluoreszenzspektroskopischer Techniken und die 
gezielte Auswahl geeigneter modifizierter BsoBI Varianten war es so möglich, die 
Konformationsdynamik bei der Bindung und Spaltung der Substrat-DNA von BsoBI 
aufzuklären und zu modellieren. Dabei waren vor allem die Richtung der 
Konformationsänderung bei der DNA-Bindung sowie der Einfluss der Metallionen auf die 
Konformation überraschend. 
 
 
 References | 98  
 
7. References 
 
1. Arber, W., Host controlled variation, In The Bacteriophage Lambda, A.D. Hershey, 
Editor. 1971, Cold Spring Harbor Lab. Press: New York. p. 83-96. 
2. Wood, W.B., Host specificity of DNA produced by Escherichia coli: bacterial 
mutations affecting the restriction and modification of DNA. J Mol Biol, 1966. 16(1): 
p. 118-33. 
3. Wilson, G.G.,N.E. Murray, Restriction and modification systems. Annu Rev Genet, 
1991. 25: p. 585-627. 
4. Arber, W., Promotion and limitation of genetic exchange. Science, 1979. 205(4404): 
p. 361-5. 
5. Pingoud, A., M. Fuxreiter, V. Pingoud,W. Wende, Type II restriction endonucleases: 
structure and mechanism. Cell Mol Life Sci, 2005. 62(6): p. 685-707. 
6. Pingoud, A.,A. Jeltsch, Structure and function of type II restriction endonucleases. 
Nucleic Acids Res, 2001. 29(18): p. 3705-27. 
7. Bickle, T.A.,D.H. Kruger, Biology of DNA restriction. Microbiol Rev, 1993. 57(2): p. 
434-50. 
8. Raleigh, E.A., Brooks, J.E., Restriction modification systems: where they are and 
what they do, In Bacterial genomes : physical structure and analysis, F.J.d. Bruijn, 
J.R. Lupski, and G.M. Weinstock, Editors. 1998, Chapman & Hall: New York. p. 78-
92. 
9. Van Etten, J.L., Unusual life style of giant chlorella viruses. Annu Rev Genet, 2003. 
37: p. 153-95. 
10. Roberts, R.J., T. Vincze, J. Posfai,D. Macelis, REBASE--enzymes and genes for DNA 
restriction and modification. Nucleic Acids Res, 2007. 35(Database issue): p. D269-
70. 
11. Stein, D.C., J.S. Gunn, M. Radlinska,A. Piekarowicz, Restriction and modification 
systems of Neisseria gonorrhoeae. Gene, 1995. 157(1-2): p. 19-22. 
12. Jeltsch, A., Maintenance of species identity and controlling speciation of bacteria: a 
new function for restriction/modification systems? Gene, 2003. 317(1-2): p. 13-6. 
13. Marinus, M.G., DNA methylation in Escherichia coli. Annu Rev Genet, 1987. 21: p. 
113-31. 
14. Barras, F.,M.G. Marinus, The great GATC: DNA methylation in E. coli. Trends Genet, 
1989. 5(5): p. 139-43. 
15. Jones, M., R. Wagner,M. Radman, Mismatch repair of deaminated 5-methyl-cytosine. 
J Mol Biol, 1987. 194(1): p. 155-9. 
16. Lieb, M., Bacterial genes mutL, mutS, and dcm participate in repair of mismatches at 
5-methylcytosine sites. J Bacteriol, 1987. 169(11): p. 5241-6. 
17. Roberts, R.J., et al., A nomenclature for restriction enzymes, DNA methyltransferases, 
homing endonucleases and their genes. Nucleic Acids Res, 2003. 31(7): p. 1805-12. 
18. Dryden, D.T., N.E. Murray,D.N. Rao, Nucleoside triphosphate-dependent restriction 
enzymes. Nucleic Acids Res, 2001. 29(18): p. 3728-41. 
19. Murray, N.E., Type I restriction systems: sophisticated molecular machines (a legacy 
of Bertani and Weigle). Microbiol Mol Biol Rev, 2000. 64(2): p. 412-34. 
20. Meisel, A., et al., Type III restriction endonucleases translocate DNA in a reaction 
driven by recognition site-specific ATP hydrolysis. EMBO J, 1995. 14(12): p. 2958-
66. 
21. Stewart, F.J., D. Panne, T.A. Bickle,E.A. Raleigh, Methyl-specific DNA binding by 
McrBC, a modification-dependent restriction enzyme. J Mol Biol, 2000. 298(4): p. 
611-22. 
 References | 99  
 
22. Sutherland, E., L. Coe,E.A. Raleigh, McrBC: a multisubunit GTP-dependent 
restriction endonuclease. J Mol Biol, 1992. 225(2): p. 327-48. 
23. Pingoud, A.,A. Jeltsch, Recognition and cleavage of DNA by type-II restriction 
endonucleases. Eur J Biochem, 1997. 246(1): p. 1-22. 
24. Perona, J.J., Type II restriction endonucleases. Methods, 2002. 28(3): p. 353-64. 
25. Imhof, P., S. Fischer,J.C. Smith, Catalytic mechanism of DNA backbone cleavage by 
the restriction enzyme EcoRV: a quantum mechanical/molecular mechanical analysis. 
Biochemistry, 2009. 48(38): p. 9061-75. 
26. Williams, R.J., Restriction endonucleases: classification, properties, and applications. 
Mol Biotechnol, 2003. 23(3): p. 225-43. 
27. Gowers, D.M., S.R. Bellamy,S.E. Halford, One recognition sequence, seven 
restriction enzymes, five reaction mechanisms. Nucleic Acids Res, 2004. 32(11): p. 
3469-79. 
28. Chandrasegaran, S.,H.O. Smith, Amino acid sequence homologies among twenty-five 
restriction endonucleases and methylases, In Structure and Expression. From proteins 
to ribosomes, R.H. Sarma and M.H. Sarma, Editors. 1988, Adenine Press: New York. 
p. 149-156. 
29. Lauster, R., T.A. Trautner,M. Noyer-Weidner, Cytosine-specific type II DNA 
methyltransferases. A conserved enzyme core with variable target-recognizing 
domains. J Mol Biol, 1989. 206(2): p. 305-12. 
30. Bestor, T., A. Laudano, R. Mattaliano,V. Ingram, Cloning and sequencing of a cDNA 
encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the 
mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol, 
1988. 203(4): p. 971-83. 
31. Lauster, R., Evolution of type II DNA methyltransferases. A gene duplication model. J 
Mol Biol, 1989. 206(2): p. 313-21. 
32. Posfai, J., A.S. Bhagwat, G. Posfai,R.J. Roberts, Predictive motifs derived from 
cytosine methyltransferases. Nucleic Acids Res, 1989. 17(7): p. 2421-35. 
33. Klimasauskas, S., J.L. Nelson,R.J. Roberts, The sequence specificity domain of 
cytosine-C5 methylases. Nucleic Acids Res, 1991. 19(22): p. 6183-90. 
34. Wilke, K., et al., Sequential order of target-recognizing domains in multispecific 
DNA-methyltransferases. EMBO J, 1988. 7(8): p. 2601-9. 
35. Ruan, H., et al., Cloning and sequence comparison of AvaI and BsoBI restriction-
modification systems. Mol Gen Genet, 1996. 252(6): p. 695-9. 
36. Ruan, H., K.D. Lunnen, J.J. Pelletier,S. Xu, Overexpression of BsoBI restriction 
endonuclease in E. coli, purification of the recombinant BsoBI, and identification of 
catalytic residues of BsoBI by random mutagenesis. Gene, 1997. 188(1): p. 35-9. 
37. Roberts, R.J.,D. Macelis, REBASE--restriction enzymes and methylases. Nucleic 
Acids Res, 1996. 24(1): p. 223-35. 
38. van der Woerd, M.J., J.J. Pelletier, S. Xu,A.M. Friedman, Restriction enzyme BsoBI-
DNA complex: a tunnel for recognition of degenerate DNA sequences and potential 
histidine catalysis. Structure, 2001. 9(2): p. 133-44. 
39. Aggarwal, A.K., Structure and function of restriction endonucleases. Curr Opin Struct 
Biol, 1995. 5(1): p. 11-9. 
40. Xie, X.S.,J.K. Trautman, Optical studies of single molecules at room temperature. 
Annu Rev Phys Chem, 1998. 49: p. 441-80. 
41. Lakowicz, J.R., Principles of fluorescence spectroscopy. 3rd ed. 2006, New York: 
Springer. xxvi, 954 p. 
42. Mukhopadhyay, S.,A.A. Deniz, Fluorescence from diffusing single molecules 
illuminates biomolecular structure and dynamics. J Fluoresc, 2007. 17(6): p. 775-83. 
 References | 100  
 
43. Moerner, W.E.,M. Orrit, Illuminating single molecules in condensed matter. Science, 
1999. 283(5408): p. 1670-6. 
44. Xie, X.S., Single-Molecule Spectroscopy and Dynamics at Room Temperature. 
Accounts of Chemical Research, 1996. 29(12): p. 598-606. 
45. Weiss, S., Fluorescence spectroscopy of single biomolecules. Science, 1999. 
283(5408): p. 1676-83. 
46. Roy, R., S. Hohng,T. Ha, A practical guide to single-molecule FRET. Nat Methods, 
2008. 5(6): p. 507-16. 
47. Lakowicz, J.R.,G. Weber, Quenching of protein fluorescence by oxygen. Detection of 
structural fluctuations in proteins on the nanosecond time scale. Biochemistry, 1973. 
12(21): p. 4171-9. 
48. Wagner, G., Characterization of the distribution of internal motions in the basic 
pancreatic trypsin inhibitor using a large number of internal NMR probes. Q Rev 
Biophys, 1983. 16(1): p. 1-57. 
49. Englander, S.W.,N.R. Kallenbach, Hydrogen exchange and structural dynamics of 
proteins and nucleic acids. Q Rev Biophys, 1983. 16(4): p. 521-655. 
50. Benkovic, S.J.,S. Hammes-Schiffer, Biochemistry. Enzyme motions inside and out. 
Science, 2006. 312(5771): p. 208-9. 
51. Hammes-Schiffer, S.,S.J. Benkovic, Relating protein motion to catalysis. Annu Rev 
Biochem, 2006. 75: p. 519-41. 
52. Frauenfelder, H., S.G. Sligar,P.G. Wolynes, The energy landscapes and motions of 
proteins. Science, 1991. 254(5038): p. 1598-603. 
53. Winkler, F.K., et al., The crystal structure of EcoRV endonuclease and of its 
complexes with cognate and non-cognate DNA fragments. EMBO J, 1993. 12(5): p. 
1781-95. 
54. Newman, M., et al., Structure of restriction endonuclease bamhi phased at 1.95 A 
resolution by MAD analysis. Structure, 1994. 2(5): p. 439-52. 
55. Viadiu, H.,A.K. Aggarwal, The role of metals in catalysis by the restriction 
endonuclease BamHI. Nat Struct Biol, 1998. 5(10): p. 910-6. 
56. Boehr, D.D., H.J. Dyson,P.E. Wright, An NMR perspective on enzyme dynamics. 
Chem Rev, 2006. 106(8): p. 3055-79. 
57. Th. Förster, Zwischenmolekulare Energiewanderung und Fluoreszenz. Annalen der 
Physik, 1948. 437(1-2): p. 55-75. 
58. Stryer, L.,R.P. Haugland, Energy transfer: a spectroscopic ruler. Proc Natl Acad Sci 
U S A, 1967. 58(2): p. 719-26. 
59. Selvin, P.R., Fluorescence resonance energy transfer. Methods Enzymol, 1995. 246: 
p. 300-34. 
60. Selvin, P.R., The renaissance of fluorescence resonance energy transfer. Nat Struct 
Biol, 2000. 7(9): p. 730-4. 
61. Ha, T., et al., Probing the interaction between two single molecules: fluorescence 
resonance energy transfer between a single donor and a single acceptor. Proc Natl 
Acad Sci U S A, 1996. 93(13): p. 6264-8. 
62. Nie, S.,R.N. Zare, Optical detection of single molecules. Annu Rev Biophys Biomol 
Struct, 1997. 26: p. 567-96. 
63. Yang, H., et al., Protein conformational dynamics probed by single-molecule electron 
transfer. Science, 2003. 302(5643): p. 262-6. 
64. Hanson, J.A., et al., Illuminating the mechanistic roles of enzyme conformational 
dynamics. Proc Natl Acad Sci U S A, 2007. 104(46): p. 18055-60. 
65. Rothwell, P.J., et al., Multiparameter single-molecule fluorescence spectroscopy 
reveals heterogeneity of HIV-1 reverse transcriptase:primer/template complexes. Proc 
Natl Acad Sci U S A, 2003. 100(4): p. 1655-60. 
 References | 101  
 
66. Weiss, S., Measuring conformational dynamics of biomolecules by single molecule 
fluorescence spectroscopy. Nat Struct Biol, 2000. 7(9): p. 724-9. 
67. Kirsch, R.D.,E. Joly, An improved PCR-mutagenesis strategy for two-site mutagenesis 
or sequence swapping between related genes. Nucleic Acids Res, 1998. 26(7): p. 
1848-50. 
68. Clegg, R.M., Fluorescence resonance energy transfer and nucleic acids. Methods 
Enzymol, 1992. 211: p. 353-88. 
69. Kuzmic, P., Program DYNAFIT for the analysis of enzyme kinetic data: application to 
HIV proteinase. Anal Biochem, 1996. 237(2): p. 260-73. 
70. Widengren, J., et al., Single-molecule detection and identification of multiple species 
by multiparameter fluorescence detection. Anal Chem, 2006. 78(6): p. 2039-50. 
71. Antonik, M., S. Felekyan, A. Gaiduk,C.A. Seidel, Separating structural 
heterogeneities from stochastic variations in fluorescence resonance energy transfer 
distributions via photon distribution analysis. J Phys Chem B, 2006. 110(13): p. 6970-
8. 
72. Allen, W.J., P.J. Rothwell,G. Waksman, An intramolecular FRET system monitors 
fingers subdomain opening in Klentaq1. Protein Sci, 2008. 17(3): p. 401-8. 
 
 | 102  
 
Supplementary information 
 
The sequence of the wild type BsoBI restriction enzyme, without the His-tag is given below: 
 
L N T Q K P F E N H L K S V D D L K T T Y E E Y R A G F I A F A L E K N K R S T P Y 
I E R A R A L K V A A S V A K T P K D L L Y L E D I Q D A L L Y A S G I S D K A K K 
F L T E D D K K E S I N N L I E N F L E P A G E E F I D E L I F R Y L L F Q G D S L G 
G T M R N I A G A L A Q Q K L T R A I I S A L D I A N I P Y K W L D S R D K K Y T N 
W M D K P E D D Y E L E T F A K G I S W T I N G K H R T L M Y N I T V P L V K K N 
V D I C L F N C E P E I Y T P Q K V H Q Q P E K Y L L L G E L K G G I D P A G A D E 
H W K T A N T A L T R I R N K F S E K G L S P K T I F I G A A I E H S M A E E I W D 
Q L Q S G S L T N S A N L T K T E Q V G S L C R W I I N I  
 
The sequence of the wild type BsoBI restriction enzyme, with the His-tag is given below. The 
His-tag (5 histidines) is shown in red. The His-tagged variant has five additional amino acids, 
as well as serine residue introduced instead of the N-terminal leucine, in order to create a 
BamHI cleavage site. Additional amino acids are shown in green. 
 
M K H H H H H M H A K G S N T Q K P F E N H L K S V D D L K T T Y E E Y R A G 
F I A F A L E K N K R S T P Y I E R A R A L K V A A S V A K T P K D L L Y L E D I Q 
D A L L Y A S G I S D K A K K F L T E D D K K E S I N N L I E N F L E P A G E E F I D 
E L I F R Y L L F Q G D S L G G T M R N I A G A L A Q Q K L T R A I I S A L D I A N I 
P Y K W L D S R D K K Y T N W M D K P E D D Y E L E T F A K G I S W T I N G K H 
R T L M Y N I T V P L V K K N V D I A L F N S E P E I Y T P Q K V H Q Q P E K Y L L 
L G E L K G G I D P A G A D E H W K T A N T A L T R I R N K F S E K G L S P K T I F 
I G A A I E H S M A C E I W D Q L Q S G S L T N S A N L T K T E Q V G S L A R W I I 
N I  
 
Oligonucleotides used for steady state and stopped-flow experiments are presented in Table 
10. 
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Table 10 
  Sequence 
Tri-sub-up 5’-GACCACACCCGTCAGCTGATATCTCGAGGCCGGACGCAT-3’ 
Tri-sub-low 5’-ATGCGTCCGGCCTCGAGATATCAGCTGACGGGTGTGGTC-3’ 
  wt2006 upper 5’-TCTATGTCGGGTGCGGAGAAAGAGGTAATGAAATGGCAG-3’ 
wt2006 lower 5’-CTGCCATTTCATTACCTCTTTCTCCGCACCCGACATAGA-3’ 
 
Tri-sub-up/low is a specific oligonucleotide, with one BsoBI recognition site (marked in red 
box in Table 10), while wt2006 upper/lower is an unspecific oligonucleotide, with no BsoBI 
recognition site. For production of labeled oligonucleotides, lower strands were labeled at the 
5’ end with the Alexa594 fluorophore, annealed with unlabeled upper strand, and used in 
stopped flow experiments. 
 
Oligonucleotides used for single molecule experiments are presented in Table 11.  
 
Table 11 
  Sequence 
BsoBI sub12 
5’-ATACTCGAGTAT-3’ 
3'-TATGAGCTCATA-5' 
RV-A11 
5'-AAAGATATCTT-3' 
3'-   TTCTATAGAAA-5' 
 
BsoBI sub12 is a specific, self-complementary oligonucleotide, with one BsoBI recognition 
site, while RV-A11 is an unspecific oligonucleotide, without BsoBI recognition site. 
 
Primers used for site specific mutagenesis are presented in Table 12.  
 
Table 12 
    Sequence Marker enzyme 
BsoBI_S298C 
  5’-TATGGGACCAACTGCAG PstI 
 TGCGGTTCATTAACAAAC-3’ 
    
BsoBI_S54C  5’-CATTAAAAGTTGCTGCA SphI 
 TGCGTTGCAAAAACACCA-3’ 
    
BsoBI_E108C  5’-CTTTTTGGAACCTGCCG NaeI 
 GCTGCGAGTTTATAGACG-3’ 
    BsoBI_E100C  5’-AGGAGTCTATAAATAATCTCA NdeI 
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 TATGTAACTTTTTGGAACCTGC-3’ 
    
BsoBI_A153C  5’-ATAATCTCTGCCTTGGACATA NdeI 
 TGTAATATCCCTTATAAATGG-3’ 
    
BsoBI_R318C  5’-ACTGAACAAGTAGGGTCTCTCG BsaI 
 CGTGTTGGATAATTAATATATAA-3’ 
    
BsoBI_E290C  5'-ATTGAGCATAGTATGGCATG SphI 
 CGAAATATGGGACCAACTT-3’ 
    
BsoBI_D212N  5’-GTTCCACTTGTAAAAAAGA AclI 
 ACGTTAATATCGCGTTATTT-3’ 
    
BsoBI_D212A  5‘-GTTCCACTTGTAAAAAAGA AclI 
 ACGTTGCTATCGCGTTATTT-3‘ 
    
BsoBI_H253Q  
5‘-CCTGCTGGAGCGGATGAG 
BsrDI 
  CAATGGAAAACAGCAAATACT-3‘ 
 
Primers used to create the 237 bp long PCR fragment (using the plasmid pAT153 triple as a 
template), used in EMSA experiments, are listed in Table 13.  
 
Table 13 
  Sequence 
lin diff kurz 3' 5'-ATAGGCGCCAGCAACCGCACCTGTG-3' 
lin diff 1.5 for 5'-ATCGCCAGTCACTATGGCGTGC-3' 
 
Primers used to amplify the region of BsoBI containing mutations for screenings are listed in 
Table 14.  
 
Table 14 
  Sequence 
pQEfor 5'-GTATCACGAGGCCCTTTCGTCT-3' 
pQErev 5'-CATTACTGGATCTATCAACAGGAG-3' 
 
All unlabeled oligos were purchased from Biomers, while labeled oligos were purchased from 
IBA. 
 
 | 105  
 
The model of metal ion exchange, with the assumption that the exchange of Mg2+ is slow and 
the exchange of Ca2+ is fast, is presented in the following equations:  
E + Ca 
k2
k-2
ECaE + Mg
k1
k-1
EMg
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hypothesis 1: the binding of Mg2+ to the enzyme is faster than the binding of Ca2+; then: 
k1>>k2, and equation (4) becomes: 
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When the concentration of Ca2+ increases, and the concentration of Mg2+ is constant, the rate 
constant would increase; vice versa, with the increase of the Mg2+ concentration, the rate 
constant would decrease. However, the experimental data show a different metal ion influence 
on the rate constant (Figure 3.24).  
Hypothesis 2: the binding of Ca2+ to the enzyme is faster than the binding of Mg2+; then: 
k2>>k1, and equation (4) becomes: 
 
 
 
 
 
When the concentration of Ca2+ increases, and the concentration of Mg2+ is constant, the rate 
constant would decrease; vice versa, with the increase of the Mg2+ concentration, the rate 
constant would increase. This dependence is shown in Figure 3.24.  
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